200,000+ products from a single source!

sales@angenechem.com

Home > Mass Spectrometry

Mass Spectrometry


A REVIEW ON THE DETERMINATION OF ISOTOPE RATIOS OF BORON WITH MASS SPECTROMETRY

 

Suresh Kumar Aggarwal1,2* and Chen-Feng You2,3
1
Fuel Chemistry Division, Bhabha Atomic Research Centre, Trombay,
Mumbai 400085, India
2
Department of Earth Sciences, National Cheng Kung University, Tainan,
Taiwan
3
Earth Dynamic System Research Centre, NCKU, Tainan, Taiwan
Received 20 October 2015; accepted 28 December 2015
Published online in Wiley Online Library (wileyonlinelibrary.com). DOI 10.1002/mas.21490

 

 

The present review discusses different mass spectrometric techniques—viz, thermal ionization mass  spectrometry  (TIMS), inductively coupled plasma mass spectrometry (ICPMS), and secondary ion mass spectrometry  (SIMS)—  used to determine  11B/10B  isotope  ratio,  and  concentration  of boron required for various applications in earth sciences, marine geochemistry, nuclear technology, environmental, and agriculture sciences, etc. The details of the techniques-P- TIMS, which uses Cs2BO2þ, N-TIMS, which uses BO2—, and MC-ICPMS, which uses Bþ ions for bulk analysis or B— and  Bþ ions for in situ micro-analysis  with  SIMS—are  highlighted. The capabilities, advantages, limitations, and problems in each mass spectrometric technique are summa- rized. The results of international interlaboratory compari-son experiments conducted  at  different  times  are summarized. The certified isotopic reference materials avail- able for boron are also listed. Recent developments in laser ablation (LA) ICPMS and QQQ-ICPMS for  solids  analysis and MS/MS analysis, respectively, are included. The different aspects of sample preparation and analytical chemistry of boron are summarized. Finally, the future requirements of boron isotope ratios for future applications are also given. Presently, MC-ICPMS provides the best precision and accuracy (0.2–0.4‰) on isotope ratio measurements,  whereas N-TIMS holds the potential to analyze smallest amount of boron, but has the issue of bias ( 2‰ to 4‰) which needs further investigations. # 2016 Wiley Period- icals, Inc. Mass Spec Rev 9999: 1–21, 2016.


Keywords: boron; mass spectrometry; thermal ionization mass spectrometry; inductively coupled plasma mass spectrometry; secondary ion mass spectrometry; laser ablation; isotopic reference materials; nuclear technology; marine science; geo- and earth sciences; B/Ca ratio

 

I.INTRODUCTION

Boron (B) is a light element that has two isotopes 10B and11B with 19.9 atom% and 80.1 atom% abundances, respectively.
Boron exists in solution in two forms—viz, trigonal boric acid B(OH)3 and tetrahedral borate anion B(OH)4—. These two forms equilibrate  in  solution,  and  their  relative  proportions depend upon the pH of the solution, as given below

Trigonal B(OH)3 is predominant in acidic solutions whereas the tetrahedral anionic form is predominant in basic solutions. B(OH)3 is more enriched in 11B, whereas B(OH)4— is more enriched in 10B as given below. This is because of differences in the vibrational frequencies of the two boron isotopes and the molecular coordination between boron species in solution.

 

The anionic form gets incorporated into marine organisms (i.e., the corals or foraminifera shells) during their growth in the sea from calcium carbonates and thus 11B/10B isotope ratio in marine carbonates is a useful proxy for paleo-pH and thus paleo- CO2 (Vengosh et al., 1991; Hemming & Hanson, 1992). The dissociation constant (pKB) between these two forms of boron is
8.8 at 281.7 K and at 35.7 practical salinity unit. This dissocia- tion constant depends upon salinity, ionic strength, temperature, pressure (Dickson, 1990; Millero, 1995), and major ion chemis- try (Hain et al., 2015). Further, boron is geochemically incompatible and has high volatility, which leads to its migration and enrichment in Earth’s upper continental crust compared to primitive mantle (Tonarini, Pennisi, & Gonfiantini, 2009).  A large isotope fractionation exists in solution with borate anion depleted in 11B. Experimentally, a value of 1.0272 0.0006 was obtained for boron isotopic equilibrium constant at 25˚C, salinity of 35 and  ionic  strength of 0.70 mol. kg—1 water (Klochko et al.,2006). Recently, an isotope fractionation factor of 26.0    1.0‰ at 25˚C was determined (Nir et al., 2015) for boron in sea water.
These data are corroborated by the ab initio molecular orbital calculations   (1.0207–1.0360   by  Oi  (2000);   1.027  by  Liu &
Tossell  (2005);  1.020–1.050  by  Zeebe  (2005);  1.026–1.028 by Rustad et al. (2010)). The residence  time of boron in sea water is about  14 Myr (Lemarchand et al., 2000) with  d11B  value  of þ39.61 0.04‰ (Lemarchand et al.,  2002a;  Simon  et  al.,  2006).  Because  the B residence time  is much  greater  than  the mixing time of the oceans (about 1,000 years), the isotopic composition of boron is uniform in sea water. It was also shown experimentally that  sea  water  is  isotopically  homogeneous with respect to  boron  with  a  mean  concentration  of  about 416 mmol. kg—1 (Foster, Pogge von Strandmann, & Rae, 2010). In   view   of   the   isotopic   homogeneity,   boron   isotopes find increasing interest to understand environmental processes. A precision of better than 1‰ (2 SD) is needed in boron isotope ratio data for pH reconstruction with a resolution of about 0.1 pH (Foster et al., 2006). The high precision of 0.2–0.4‰ in boron isotope ratio data is required at low pH, because the slope of ~o11B curve gets shallower at low pH.

 

The isotope ratios of boron show large variations in nature (Fig. 1), and are of great interest to geo-, environmental, and marine scientists (Spivack, & Palmer, Edmond, 1987; Spivack, You, & Smith, 1993; Spivack & You, 1997; Lemarchand et al., 2002b; Kubota et al., 2015). These include studies in hydrology for ground water contamination by sea water (Barth, 1997); to assess the impact of artificial recharge on water sources; to identify mechanisms of adsorption/desorption on clay minerals; and in the environment as potential tracers of contamination of ground water with coal combustion residues, etc. (Davidson & Bassett, 1993; Vengosh et al., 1994; Ruhl et al., 2014; Warner et al., 2014). B isotope ratios are also used for provenance studies in archaeology (Devulder, Degryse, & Vanhaecke, 2013; Devulder et al., 2014, 2015) and hold potential in agriculture  for  crop  plants  (Wieser et al., 2001; Rosner et al., 2011; Geilert et al., 2015).
One of the isotopes of B (10B), has a high thermal neutron absorption cross-section (about 3,800 barns) and is, therefore, a useful nuclide in nuclear technology (IAEA Report, 1995; Subramanian, Suri, & Murthy, 2010). B2O3 dissolved in heavy water (D2O) is used as a liquid poison in the moderator system of pressurized heavy-water reactors (PHWRs) to control the reactivity. B4C enriched in 10B is used in control rods in nuclear reactors. Boric acid is also used in the primary cooling circuit of pressurized water reactors (PWRs), which require regular determination of isotopic composition and concentration of boron. Boron-alloyed steels are used as shielding materials for storage containers of irradiated nuclear fuel, reactor shielding, and in instruments used to detect neutrons. The nuclear reaction of  10B  with  thermal  neutrons  produces  alpha  particles.This property of B is exploited for boron neutron capture therapy (BNCT) to destroy cancerous cells in cancer treatment (Probst et al., 1997). In contrast, in other circumstances B may be less helpful, with the presence of B in aluminum, zirconium alloy, and stainless steel—clad materials or in nuclear fuel materials detrimental to neutron economy in nuclear reactors.

 

The utilization of B for palaeo-proxies, geology, archaeol- ogy, agriculture, nuclear technology, and medicine requires B isotopic composition data, which can be determined by various mass spectrometric techniques. The various mass spectrometric techniques used are thermal ionization mass spectrometry, inductively coupled plasma source mass spectrometry and secondary ion mass spectrometry. Because boron has a high first ionization potential (8.3 eV), generation of Bþ ions is not possible in TIMS. For the same reason, the yield of Bþ ions in an inductively coupled plasma (ICP) source is relatively low (about 50–60%), which necessitates solutions containing about 20 ppb of boron. Further, a difference of about 10% in the atomic masses of the two boron isotopes (i.e., 1 in 10) contributes to isotope fractionation or mass discrimination during their mass spectrometric analysis. In addition, the sticky nature of boron to various parts of the mass spectrometer causes memory effect or carry over in mass spectrometric analysis with ICPMS. This memory effect poses a severe problem when samples with widely varying boron isotopic ratios are analyzed, with an inductively coupled plasma source mass spectrometer.
The analytical chemistry of boron is challenging due to the propensity for contamination of boron from apparatus (e.g., borosilicate glass), chemicals, personnel, and laboratory envi- ronment during wet chemistry (Downing et al., 1998). At the same time, boron can be lost during separation and purification steps due to its volatile nature, which leads to incomplete recoveries. There can be fractionation between the two boron isotopes during chemical separations (Lemarchand et al., 2002a) and volatilization due to relative large mass difference between the two isotopes. Mass spectrometric techniques like P-TIMS and ICP-MS demand boron to be free from matrix and major abundant elements in the sample to achieve high sensitivity and high precision and accuracy to determine B isotope ratios. The small changes in 11B/10B isotope ratio are expressed in delta (d) notation (per mil), which is defined as


Precise and accurate determination of d11B in various samples (geological, biological, environmental etc.) demands the sample to be completely dissolved followed by separation and purification of boron. Great care has to taken to prevent B contamination even when working in an ultra-clean laboratory (Rosner, Romer, & Meixner, 2005). It was shown that boron- rich fibrous silicate glass filters should not be used in laborato- ries where samples with small amounts of boron are handled, and the glass filters should be replaced with synthetic poly- carbon filters made of polyethylene/polystyrole, which reduce the boron blank by an order of magnitude (Rosner, Romer, & Meixner, 2005). Also the laboratory ware to be used should be of Teflon, PFA, and  properly  leached  prior to use  (Downing et al., 1998). All chemicals should be of ultra-high purity, and acids used should be sub-boiling distilled.

 

In addition to great interest to obtain precise and accurate data on d11B, B/Ca ratio is important because this ratio in foraminifera samples is dependent on the partition coefficient of boron between sea water and calcium carbonate (calcite or aragonite). B/Ca ratio can, therefore, provide direct information on the [B(OH)4—/HCO3—] ratio of the sea water, because the amount of boron precipitated in the biological/inorganic carbon- ate is known to increase with increasing pH (Yu & Elderfield, 2007; Yu et al., 2010). Recent reports, however, show that B/Ca amount ratio is not a robust proxy and extensive careful studies are needed to evaluate its usefulness for the past ocean carbonate system (Allen & H€onisch, 2012; Babila et al., 2014; Henehan et al., 2015; Uchikawa et al., 2015).


The present review is written with the objective to summa- rize and highlight the scientific and technological advances that have taken place in the last two decades for the mass spectrometric analysis of boron (Hemming & Hanson, 1994; Al- Ammar, Reitznerova, & Barnes, 2000; Lemarchand et al., 2002a; Aggarwal et al., 2004; Albarede and Bear, 2004; Foster, 2008; Guerrot et al., 2010; Pennisi et al., 2011; Rae et al., 2011; McCulloch et al., 2014). The advancements are mainly because of two reasons: one is the availability of advanced fully automated multi-collector based high sensitivity thermal ioniza- tion and inductively coupled plasma mass spectrometers (MC- TIMS  and  MC-ICPMS)  capable  to  provide  high  precision (better than 0.2‰) and secondly, an increasing interest in the bio-geochemistry of boron, particularly for marine carbonates, which serves as a proxy for paleo-pH and paleo-CO2 levels. Further, extensive experience in different international laborato- ries to determine isotope ratios of boron has highlighted the advantages and limitations of various methodologies to deter- mine accurate isotope ratios, that circumvent various problems like isotope fractionation in TIMS, memory effect in ICPMS, and validation of the methodologies with recently available certified isotopic reference materials. Also, techniques like laser ablation (LA) ICPMS and secondary ion mass spectrometry (SIMS) have added a new dimension to the in situ micro- analysis of boron in different geological and other solid materials. These aspects are also discussed in this review.

 

 

II.ANALYTICAL METHODOLOGY FOR EXTRACTION AND PURIFICATION OF BORON

Mass spectrometric analysis of boron with TIMS and ICPMS requires boron to be in a relatively pure chemical form to minimize matrix effects, organic isobaric interferences and suppression of ionization in the thermal ion source (Hemming & Hanson, 1994; Farhat, Ahmad, & Arafat, 2013). A number of approaches have been used to fulfil this requirement (Sah & Brown, 1997). The extraction and purification methods include solvent extraction, ion-exchange, micro-sublimation, etc. Among these methods, ion exchange procedure (Van Hoecke  et al., 2014; He et al., 2015a) has been used more often. Micro- sublimation is also popular these days due to the advantages of efficient matrix removal, labor intensiveness, cost of consum- ables, procedural blank, and throughput (Van Hoecke et al., 2014). A brief description of these methods is given below.


The solid rock samples require extraction of boron that use fusion with NaOH, Na2CO3; pyro-hydrolysis, or acid dissolution (Aggarwal & Palmer, 1995). For example, boron can be extracted from borates and tourmaline (a complex alumina–silicate material) with fusion or pyro-hydrolysis. Pyro-hydrolysis consists of passing steam over the sample kept in a crucible (Pt) heated to high temperature (more than 1,000˚C) and collecting the condensate (Aggarwal & Palmer, 1995). This method provides a relatively pure fraction of boron unless the sample contains other volatile elements like sulfur, which require further purification. Fusion with Na2CO3 (flux: rock 8:1) or NaOH (5:1) offers the advantage that a large amount of solids that contain small amounts of boron can be taken up for fusion (Aggarwal & Palmer, 1995). Solid samples can also be dissolved with different acids like HF, perchloric acid, and nitric acid (Sah & Brown, 1997; Robinson, Skelly Frame, & Frame, 2014). Care has to be exercised with HF in view of the fact that BF3 is volatile in nature. Addition of small amounts of mannitol during acid dissolution prevents the loss of boron (Chen, Lin, & Yang, 1991; Nakamura et al., 1992). Care should be taken to use high purity acids, and also Teflon ware is a must with HF (Robinson, Skelly Frame, & Frame, 2014).

Boron extracted with the above procedures is further purified either with methyl borate distillation or more commonly with B- specific or non-specific ion-exchange resin columns (Aggarwal & Palmer, 1995). Distillation is based on the fact that trimethyl borate is volatile. The distillate will also include other volatile elements like halogens, Na, etc., which can be removed by passing the solution through a mixed cation-anion exchange resin bed treated with HCl and NaOH to convert the resin into Hþ and OH— forms, respectively. Boron can be eluted from the column with high purity water with cations and anions retained on the resin bed.


In biogenic carbonates, boron is generally separated and purified from the matrix with ion-exchange procedures. The foraminiferal carbonate tests (1–3 mg) are first cracked open with gentle crushing of the moist samples, in between the two clean glass plates (Barker, Greaves, & Elderfield, 2003; Rae et al., 2011; Henehan et al., 2013). The crushed samples are cleaned ultrasoni- cally with high purity water, methanol, high purity water (in sequence) to remove clay contamination. Oxidative cleaning is done for cultured and sediment samples, three to five times, with 1% H2O2 in 0.1 M NH4OH at 80˚C. Organic material is removed by oxidation with sodium hypochlorite (NaClO; 5%Cl), which is removed by repeated rinsing with high purity water. The cleaned samples are dissolved in dilute (0.1–0.5 M) HNO3 and Al/Ca ratio (<100 mmol mol—1) in the dissolved sample is monitored with high resolution ICPMS, to confirm effectiveness of the cleaning protocol. Al/Ca ratios of <50 mmol mol—1 were achieved with this protocol (Foster, 2008). Boron-specific anion exchange resin (Amberlite IRA 743) is conventionally used, either alone or preceded by a cation exchange resin column (Kiss, 1988; Leeman et al., 1991; Lemarchand et al., 2002a). Amberlite 743 contains a hydrophobic styrene backbone and a tertiary amine group (N- methyl glucamine), which is a weak base with a pKa value of about 7. The resin, therefore, behaves like an anion exchanger at pH <7 and absorbs only B(OH)4—. For example, separation of boron from seawater is given here (Foster, Pogge von Strandmann, & Rae, 2010). Seawater aliquots are mixed with a sodium acetate-acetic acid buffer to pH of about 5. The sample solution is loaded onto a micro-column (25 mL volume, 50 mesh resin). The matrix is washed with high-purity 18.2 MΩ MilliQ water, and B is eluted with 450 mL of 0.5 M HNO3. The B isotopic composition determined from different fractions collected with the IRA-743 ion exchange experiments showed that the first few fractions are enriched   in   11B   and   the   tail   fractions   are   depleted   in  11B (Lemarchand et al., 2002a). It is, therefore, important to achieve a high recovery to eliminate any isotope fractionation during ion-exchange purification. This is done by passing the sample slowly through the resin, which allows re-equilibration of the sample with resin in the column, after the initially absorbed borate is eluted slowly from the resin column. In addition, elution tails are checked for boron and the total procedural blanks are monitored for every column batch. Because B in the anionic form B(OH)4— is only absorbed onto the IRA 743 resin, some investigators propose that the B solution prior to loading on the resin column should have a pH of 10 (Rosner et al., 2011), which is achieved by adding alkali or ammonia, to eliminate isotope fractionation during boron purification. However, at this pH, Na, Mg, and Ca, if present in the sample, precipitate as hydroxide on the resin column and will elute along with boron (with HNO3 or HCl), and these ions have to be removed with another cation exchange step (Aggarwal & Palmer, 1995).

For foraminiferal shells, the amount of sample to be taken depends upon the species in view of different B concentrations in various foraminiferal species. For example, a few hundred mg (preferably 1–2 mg) of the benthic foraminiferal shells, with high B concentrations, are crushed, and rinsed and ultrasonicated with deionized water and methanol several times to remove clay materials (Yu et al., 2005). This step is generally followed by oxidative step to remove organic matter, in a clean laboratory. Oxidation with sodium hydroxide and hydrogen peroxide is done (Boyle & Keigwin, 1985; Rosenthal, Boyle, & Slowey, 1997; Barker, Greaves, & Elderfield, Yu  & Elderfield, 2007; Foster  et al., 2013; Holcomb et al., 2015). The cleaned shells are dissolved in 0.1 M HNO3 and the solution is taken up for isotopic analysis with MC-ICPMS. In another study, bleaching with sodium hypochlorite solution for 24 hr was done to oxidize the organic matter (Foster et al., 2006). These foraminiferal shells were again rinsed and ultrasonicated to remove NaClO and any dissolved salts. The cleaned foraminifer sample (calcite) was dissolved in 2 M HCl, by drop wise addition until complete carbonate dissolution (Foster et al., 2006). The purified solution was taken for N-TIMS analysis. In the case of coal-combustion residues (CCRs), effluents from leaching experiments on CCRs from a variety of coals were used to determine d11B (Davidson & Bassett, 1993; Williams & Hervig, 2004; Ruhl et al., 2014). The samples of surface water, effluents, and leachates were processed with a cation exchange resin (AG 50W-X8) to remove cations. The eluate was oxidized with H2O2 to remove organic matter and CNO complexes, prior to loading on the filament for N-TIMS analysis (Ruhl et al., 2014). Detailed studies are reported recently (Holcomb et al., 2015) for cleaning and pre-treatment procedures for biogenic and synthetic calcium carbonates formed in marine environments. Cleaning protocols that cause partial dissolution are troublesome for compositionally heterogeneous samples, and boron isotopes are always robust to sample pre-treatment cleaning procedures (Holcomb et al., 2015).

Studies were reported for evaporation and sublimation of boric acid to purify boron from organic-rich solutions (Gaillar- det et al., 2001). It was shown that slow evaporation of boron solution in dil. HCl medium, over a period of 10–12 hr, at 60– 65˚C gave complete B recovery without any isotope fraction- ation and boron loss. On heating the dried residue for more than 1 hr, loss of boron was observed. The recovery of boron in micro-sublimation experiments was confirmed with isotope dilution experiments, and the absence of any isotopic fraction- ation was confirmed with NIST certified B isotopic reference material (Gaillardet et al., 2001). It was also proved that mannitol addition is not necessary with this procedure of micro- sublimation. Boron loss was observed if the dried residue was heated beyond 1 hr, or a higher temperature was used for boron solution evaporation and sublimation. For these experiments with high temperature sublimation or heating of dried residue for longer durations, addition of mannitol was necessary to form a solid matrix of non-volatile boron ester to avoid the boron loss (Ishikawa & Nakamura, 1990). The micro-sublimation proce- dure was also found useful to separate boron from organic rich media, in contrast to other methods like the use of activated carbon, H2O2, organic matter specific resin or UV irradiation (Lemarchand et al., 2002a). Recently, this micro-sublimation was used (Wang et al., 2010; Liu et al., 2013; Pi et al., 2014) for rock samples, marine carbonate, sea water, and Porites coral samples with an aim to avoid introduction of organic residue to the purified sample through the ion-exchange procedure. The quantitative recovery of boron from sea water and coral sample (Liu et al., 2013) was confirmed by the standard addition method (Foster et al., 2006). The procedure involved the addition of a known amount of SRM 951a standard to a sample before micro- sublimation and to another set of the same sample after sublimation, followed by the measurement of 11B/10B isotopic ratios in the two mixtures to calculate the boron concentration. For the natural rock samples, doping with NaCl was necessary, prior to micro-sublimation, to recover boron from the digested silicates of the rock samples (Pi et al., 2014). The procedure is based on the fact that boron sublimates at a relatively low temperature (about 70˚C) to leave the organic and alkaline matrices in solution or solid form. Further separation with resins and additional H2O2 treatment is not required, and elimination of this separation step leads to low blanks in the separation procedure. The procedure involves taking a small volume of the boron-containing solution into the 5-mL conic bottom PFA vial, and setting it upside down so that the cap can be heated (about 70˚C for 12 hr) and the top conical end can be cooled for condensation of the evaporated boron. The benefits of low- blank, high-throughput, and quantitative recovery can be realized with the micro-sublimation method (Van Hoecke et al., 2014). A comparison of the micro-sublimation and anion exchange procedure for four different matrices, that is, Ca aqueous solution (20 g L—1), seawater, digests  of  spinach  (100 g L—1) and silicate glass (10 g L—1), spiked with B standards showed good agreement in the chemical recoveries with the two methods, without any isotopic fractionation, except in spinach digests (Van Hoecke et al., 2014). Poor yield and isotopic fractionation observed in the spinach digests was attributed to the preferential adsorption of 10B, present as tetrahedral anion, to the organics present in undissolved portion of the sample.

For nuclear samples (e.g., titanium borides), a small amount of the sample is crushed and disintegrated with concentrated HNO3. The slurry is taken up in 0.5 M HNO3, and a small portion is loaded onto the filament and fused with rubidium carbonate on the filament, at alkaline pH, for boron isotope analysis with positive ions MC-TIMS (Rao et al., 2014). For the periodic analysis of heavy water from PHWRs to determine the concentration of boron, the solution is spiked with a known amount of pre-calibrated 10B enriched spike (Heumann, 1992) and pre-concentrated by heating under an infra-red lamp in a fumehood, prior to boron isotope analysis with P-TIMS. The solution is not allowed to dry-up, in the pre-concentration step, to eliminate the isotope fractionation effects. Solid boric acid or B2O3 samples for B isotope analysis are taken directly and fused with alkali carbonate on the filament. Solid samples like uranium oxide and aluminum, are first dissolved in suitable acids—for example, HNO3 for uranium and HCl for Al. Boron can be separated from different matrices in a 1 M HCl medium, by using solvent extraction with 0.65M solution of 2-ethyl- hexane 1,3 diol (EHD) in 10% chloroform (Rao & Aggarwal, 2008). In the nuclear samples (except in case of nuclear fuels and clad materials [aluminum, zircaloy, stainless steel], where boron is undesirable), the amount of boron present is generally not a limitation, but the blank and laboratory contamination need to be controlled and monitored carefully.

For crop plant samples, dry ashing at 600˚C in a microwave oven was used (Rosner et al., 2011). The ash was dissolved in 0.5 M HCl, and the solution was used to separate and purify boron with a 3-step ion chromatography procedure. The first step was to remove most of the cations with AG 50Wx8 resin on a polypropylene column. A boron solution was loaded under low- pH conditions so that boron was present as neutral B(OH)3 and is not adsorbed by the resin in contrast to all other cations. This step was proceeded by second and third steps of anion exchange purification with Amberlite IRA-743 boron-specific anion ex- change resin. In this step, the pH of the boron-containing solution was adjusted to >11 with aqueous NaOH so that B was present as B(OH)4— and was loaded onto the resin column. The boron fraction was eluted with 0.5 M HCl and mixed with mannitol (40 mg mannitol/1 mg of boron), followed by slow evaporation to dryness. No loss of boron was observed during dry ashing of these biological materials. A similar observation was reported (Noda & Ito, 2008) in coal combustion, where no loss of boron was observed under reducing conditions.

Among all the analytical methods discussed above, boron separation and purification with boron specific anion exchange resin IRA-743 is the most commonly used approach (He et al., 2015b) at various laboratories.


For foraminiferal shells, the amount of sample to be taken depends upon the species in view of different B concentrations in various foraminiferal species. For example, a few hundred mg (preferably 1–2 mg) of the benthic foraminiferal shells, with high B concentrations, are crushed, and rinsed and ultrasonicated with deionized water and methanol several times to remove clay materials (Yu et al., 2005). This step is generally followed by oxidative step to remove organic matter, in a clean laboratory. Oxidation with sodium hydroxide and hydrogen peroxide is done (Boyle & Keigwin, 1985; Rosenthal, Boyle, & Slowey, 1997; Barker, Greaves, & Elderfield, Yu  & Elderfield, 2007; Foster  et al., 2013; Holcomb et al., 2015). The cleaned shells are dissolved in 0.1 M HNO3 and the solution is taken up for isotopic analysis with MC-ICPMS. In another study, bleaching with sodium hypochlorite solution for 24 hr was done to oxidize the organic matter (Foster et al., 2006). These foraminiferal shells were again rinsed and ultrasonicated to remove NaClO and any dissolved salts. The cleaned foraminifer sample (calcite) was dissolved in 2 M HCl, by drop wise addition until complete carbonate dissolution (Foster et al., 2006). The purified solution was taken for N-TIMS analysis. In the case of coal-combustion residues (CCRs), effluents from leaching experiments on CCRs from a variety of coals were used to determine d11B (Davidson & Bassett, 1993; Williams & Hervig, 2004; Ruhl et al., 2014). The samples of surface water, effluents, and leachates were processed with a cation exchange resin (AG 50W-X8) to remove cations. The eluate was oxidized with H2O2 to remove organic matter and CNO complexes, prior to loading on the filament for N-TIMS analysis (Ruhl et al., 2014). Detailed studies are reported recently (Holcomb et al., 2015) for cleaning and pre-treatment procedures for biogenic and synthetic calcium carbonates formed in marine environments. Cleaning protocols that cause partial dissolution are troublesome for compositionally heterogeneous samples, and boron isotopes are always robust to sample pre-treatment cleaning procedures (Holcomb et al., 2015).

 


Studies were reported for evaporation and sublimation of boric acid to purify boron from organic-rich solutions (Gaillar- det et al., 2001). It was shown that slow evaporation of boron solution in dil. HCl medium, over a period of 10–12 hr, at 60– 65˚C gave complete B recovery without any isotope fraction- ation and boron loss. On heating the dried residue for more than 1 hr, loss of boron was observed. The recovery of boron in micro-sublimation experiments was confirmed with isotope dilution experiments, and the absence of any isotopic fraction- ation was confirmed with NIST certified B isotopic reference material (Gaillardet et al., 2001). It was also proved that mannitol addition is not necessary with this procedure of micro- sublimation. Boron loss was observed if the dried residue was heated beyond 1 hr, or a higher temperature was used for boron solution evaporation and sublimation. For these experiments with high temperature sublimation or heating of dried residue for longer durations, addition of mannitol was necessary to form a solid matrix of non-volatile boron ester to avoid the boron loss (Ishikawa & Nakamura, 1990). The micro-sublimation proce- dure was also found useful to separate boron from organic rich media, in contrast to other methods like the use of activated carbon, H2O2, organic matter specific resin or UV irradiation (Lemarchand et al., 2002a). Recently, this micro-sublimation was used (Wang et al., 2010; Liu et al., 2013; Pi et al., 2014) for rock samples, marine carbonate, sea water, and Porites coral samples with an aim to avoid introduction of organic residue to the purified sample through the ion-exchange procedure. The quantitative recovery of boron from sea water and coral sample (Liu et al., 2013) was confirmed by the standard addition method (Foster et al., 2006). The procedure involved the addition of a known amount of SRM 951a standard to a sample before micro- sublimation and to another set of the same sample after sublimation, followed by the measurement of 11B/10B isotopic ratios in the two mixtures to calculate the boron concentration. For the natural rock samples, doping with NaCl was necessary, prior to micro-sublimation, to recover boron from the digested silicates of the rock samples (Pi et al., 2014). The procedure is based on the fact that boron sublimates at a relatively low temperature (about 70˚C) to leave the organic and alkaline matrices in solution or solid form. Further separation with resins and additional H2O2 treatment is not required, and elimination of this separation step leads to low blanks in the separation procedure. The procedure involves taking a small volume of the boron-containing solution into the 5-mL conic bottom PFA vial, and setting it upside down so that the cap can be heated (about 70˚C for 12 hr) and the top conical end can be cooled for condensation of the evaporated boron. The benefits of low- blank, high-throughput, and quantitative recovery can be realized with the micro-sublimation method (Van Hoecke et al., 2014). A comparison of the micro-sublimation and anion exchange procedure for four different matrices, that is, Ca aqueous solution (20 g L—1), seawater, digests  of  spinach  (100 g L—1) and silicate glass (10 g L—1), spiked with B standards showed good agreement in the chemical recoveries with the two methods, without any isotopic fractionation, except in spinach digests (Van Hoecke et al., 2014). Poor yield and isotopic fractionation observed in the spinach digests was attributed to the preferential adsorption of 10B, present as tetrahedral anion, to the organics present in undissolved portion of the sample.

 


For nuclear samples (e.g., titanium borides), a small amount of the sample is crushed and disintegrated with concentrated HNO3. The slurry is taken up in 0.5 M HNO3, and a small portion is loaded onto the filament and fused with rubidium carbonate on the filament, at alkaline pH, for boron isotope analysis with positive ions MC-TIMS (Rao et al., 2014). For the periodic analysis of heavy water from PHWRs to determine the concentration of boron, the solution is spiked with a known amount of pre-calibrated 10B enriched spike (Heumann, 1992) and pre-concentrated by heating under an infra-red lamp in a fumehood, prior to boron isotope analysis with P-TIMS. The solution is not allowed to dry-up, in the pre-concentration step, to eliminate the isotope fractionation effects. Solid boric acid or B2O3 samples for B isotope analysis are taken directly and fused with alkali carbonate on the filament. Solid samples like uranium oxide and aluminum, are first dissolved in suitable acids—for example, HNO3 for uranium and HCl for Al. Boron can be separated from different matrices in a 1 M HCl medium, by using solvent extraction with 0.65M solution of 2-ethyl- hexane 1,3 diol (EHD) in 10% chloroform (Rao & Aggarwal, 2008). In the nuclear samples (except in case of nuclear fuels and clad materials [aluminum, zircaloy, stainless steel], where boron is undesirable), the amount of boron present is generally not a limitation, but the blank and laboratory contamination need to be controlled and monitored carefully.

 


For crop plant samples, dry ashing at 600˚C in a microwave oven was used (Rosner et al., 2011). The ash was dissolved in 0.5 M HCl, and the solution was used to separate and purify boron with a 3-step ion chromatography procedure. The first step was to remove most of the cations with AG 50Wx8 resin on a polypropylene column. A boron solution was loaded under low- pH conditions so that boron was present as neutral B(OH)3 and is not adsorbed by the resin in contrast to all other cations. This step was proceeded by second and third steps of anion exchange purification with Amberlite IRA-743 boron-specific anion ex- change resin. In this step, the pH of the boron-containing solution was adjusted to >11 with aqueous NaOH so that B was present as B(OH)4— and was loaded onto the resin column. The boron fraction was eluted with 0.5 M HCl and mixed with mannitol (40 mg mannitol/1 mg of boron), followed by slow evaporation to dryness. No loss of boron was observed during dry ashing of these biological materials. A similar observation was reported (Noda & Ito, 2008) in coal combustion, where no loss of boron was observed under reducing conditions.
Among all the analytical methods discussed above, boron separation and purification with boron specific anion exchange resin IRA-743 is the most commonly used approach (He et al., 2015b) at various laboratories.

 

 

III.MASS SPECTROMETRIC TECHNIQUES USED TO ANALYZE BORON

A.Thermal Ionization Mass Spectrometry (TIMS)

1.Positive-TIMS
The high first- ionization potential of boron (about 8.3 eV) prevents the formation of Bþ ions with surface ionization in TIMS. Instead, alkali metal borate ions (M2BO2þ) are conven- tionally used for P-TIMS analysis of boron isotopes (DeBievre & Debus, 1969; Xiao, Beary, & Fassett, 1988; Vengosh et al., 1991; Nakano & Nakamura, 1998; Xiao & Wang, 1998; Ishikawa & Nagaishi, 2010). Different alkali metals (Li, Na, K, Rb, and Cs) have been used to generate positive meta-borate ions (Ramakumar et al., 1985; Spivack & Edmond, 1986; Nakamura et al., 1992; Ding & Zhao, 1994; Sahoo & Masuda, 1995; Catanzaro et al., 1970; Deyhle, 2001; Rao et al., 2008, 2010a). To efficiently generate M2BO2þ ions and reduce the intensity of alkali metal ions, a special loading procedure (e.g., loading of graphite as a promoter and an optimum B/alkali metal mole ratio) needs to be employed. Among the different alkali metals, Na and Cs metal borates are employed quite often in view of the fact that both Na and Cs are mono-isotopic and do not complicate the mass spectra. The 11B/10B isotope ratio can be conveniently calculated by measuring the ion intensities at 89/88 (Na2BO2þ) and 309/308 (Cs2BO2þ), with the exception to apply a small correction for an 17O contribution at masses 89 and 309. The correction of 17O contribution is straightforward and is accounted for by subtraction of  2  (17O/16O) isotope  ratio value from the measured isotope ratio data. Between the two mono-isotopic alkali metals (Na and Cs), Cs is preferred in view of the high mass of the Cs2BO2þ ion, and this high mass minimizes the mass-dependent isotope fractionation, which is a source of variable systematic error in TIMS. This isotope fractionation is not a constant factor in TIMS, and depends on various parameters including the mass to charge ratio of the ions monitored in P-TIMS and N-TIMS. A high purity tantalum single-filament assembly is generally used for P-TIMS analysis. Because the use of Cs2BO2þ in a static mode of data collection was not possible with early models of TIMS, some laboratories continue to use Na2BO2þ ion in P-TIMS analysis. The continued use of Na2BO2þ ion is also partly due to the long experience of these laboratories in successful use of Na2BO2þ for isotope ratio measurements of boron (Rao et al., 2008, 2009; Rao, Parab, & Aggarwal, 2012).

For many years, the mechanism of formation of alkali metal borate ions remained elusive. During the past decade, a few interesting studies are reported by a few researchers (Lakshmi Narasimhan et al., 2013; Wei et al., 2011) that have shed light onto the mechanism of formation of M2BO2þ ions in TIMS. Studies were reported that used Raman spectroscopy and transmission electron spectroscopy (TEM) to compare the role of different carbon-based materials (e.g., graphite, carbon, fullerene, single-walled carbon nanotube SWNT; Wei et al., 2011). Based on the micro-structure properties of these four carbon-based materials, a surface-induced collision mechanism was proposed, and graphite gives the highest yield of polyatomic ions due to its perfect parallel and equidistant layers structure (only G-band observed with the lowest FWHM in Raman spectrum) and fullerene led to the lowest yield due to a block of their pathways (Wei et al., 2011). Studies performed on the reactions of B, B2O3, and B4C with Na2CO3 with transpiration thermogravimetry (TG), TIMS, and Knudsen effusion mass spectrometry (KEMS) showed that the formation of metaborate ion is a two-step phenomenon (Lakshmi Narasimhan et al., 2013). This two step process was concluded from the NaBO2 residue found in the TG experiments of all the three forms of boron (i.e., B, B2O3 and B4C with Na2CO3) at a temperature much lower than that for Na2CO3 alone, and also the high intensity of Na2BO2+ ion observed in KEMS.



For TIMS analysis with Na2BO2+, it is generally accepted that the B/Na mole ratio needs to be strictly controlled on the filament within a narrow range when mixing with Na2CO3 or NaOH (Rao et al., 2008, 2009; Rao, Parab, & Aggarwal, 2012) to get good yield of Na2BO2þ ions. Studies (Rao et al., 2008) show that NaCl can also be used instead of Na2CO3 or NaOH, and in this case, the B/Na mole ratio need not be strictly controlled and could vary from 1 to 0.1. However, addition of mannitol, which forms an anionic complex with boron (70 mg of mannitol for about 1.7 mg of B), was essential, apart from loading of graphite on the filament. This relaxation in the strict control of the B/Na mole ratio is an advantage to analyze samples with unknown amounts of boron; e.g., in the case of ground-water samples. A subsequent study (Rao et al., 2009) demonstrated the robustness of a boron-mannitol complex on graphite-coated tantalum filament with Na2CO3 for solid samples and NaCl for solutions. With isotope dilution, P-TIMS was used to determine B at sub-ppm levels in uranium oxide samples (Rao et al., 2010b). For alloy samples of titanium boride, it was observed that graphite should be added onto the
filament only after fusion of the slurry of the alloy with Rb2CO3 (Rao et al., 2014) to get good intensity of Rb2BO2þ ions. Further, the possibility to perform internal normalization based on Rb isotope ratios was also demonstrated successfully (Rao  et al., 2010a).


Isobaric interference limitation during TIMS analysis of boron with Cs2BO2þ is discussed in many papers (Hemming & Hanson, 1992; Aggarwal & Palmer, 1995). This isobaric interference is commonly encountered in organic samples—for example, marine carbonates, and lowers the d11B values. One of the ways to minimize this organic-matter (Cs2CNOþ) interfer- ence is to digest the sample with H2O2 (Grottoli et al., 2005) prior to loading on the filament. An experimental study (Wu et al., 2012) for Archaeo-cyatha fossil carbonates determined the exact nature of the organic matter with FT-IR, Raman, and TG-DSC-MS techniques. The results showed the presence of an acylamino (–CO–NH2) group in the carbonate samples, which would negatively bias the 11B/10B isotope ratios and lower the d11B values. It was also noted that, on external addition of acetamide (CH3CONH2), the B isotope ratio gradually reaches the accurate value on heating the filament to 1.8 A in TIMS, when the organic compound is consumed on the heated filament.
Another way to circumvent the isobaric interference (Wei et al., 2004) is to add 1% H3PO4 on the filament. The addition of H3PO4 acts as an ion depressor and prevents the formation of Cs2CNOþ in the presence of nitrate, probably by changing the morphology of boron compound. The temperature of TIMS analysis of B is also higher than that in the absence of ion depressor.

 

2.Negative-TIMS

Among different mass spectrometric techniques available, N-TIMS has the highest sensitivity for isotopic analysis of boron, and can conveniently analyze  samples  that  contain  one ng or smaller amounts (150 pg) of boron (Duchateau & DeBievre, 1983; Zeininger & Heumann, 1983; Heumann & Zeininger 1985; Vengosh, Chivas, & McCulloch, 1989; Hem- ming & Hanson, 1992, 1994; Heumann  et al., 1995; Sonoda   et al., 2002; Shen & You, 2003; You, 2004). Samples like foraminifera with 1–2 ng of boron can be easily analyzed with this method. During N-TIMS, a single-filament assembly made of a zone-refined high-purity rhenium filament is used to load the sample solution. All efforts are made to minimize the isobaric interference of CNO— at m/z 42, which corresponds to 10BO2—. This minimization of isobaric interference is neces- sary, because even 0.1% of CNO—  in the ion beam will lower the 11B/10B isotope ratio by 4.7‰ compared to the exact value (Tonarini,  Pennisi, & Gonfiantini,  2009). Samples are  treated with high-purity hydrogen peroxide to remove CNO complexes and any organic matter (Pelejero et al., 2005; Foster et al., 2006). In addition, signal is monitored at m/z 26 (CN—) using secondary electron multiplier (due to its higher sensitivity compared to a Faraday cup) to confirm the absence of any signal at m/z 26 and thus of no interference at CNO—. All operations should be done in a laminar-flow clean hood equipped with boron-free PTFE HEPA filters to minimize boron contamination of the sample (Rosner, Romer, & Meix- ner, 2005). For N-TIMS, boron-free sea water is generally loaded on the filament to enhance ionization efficiency, because the electronic work function of the filament is lowered by salts present in sea water. The boron-free sea water is prepared with Amberlite IRA 743 ion-exchange resin (Barth, 1997), which introduces some organics from the resin. Another method with an alternative loading solution prepared by combining high- purity single element standard solutions of Ca2þ, Mg2þ, Naþ,  and Kþ in 5% HCl with proportions similar to those present in sea water was found to give encouraging results. This loading solution eliminates the risk of isobaric interference from CNO— and provides the possibility to perform automatic data collec- tion (Dwyer & Vengosh, 2008).


Owing to the low mass of BO2— ions, there is a problem of isotope fractionation in TIMS. This isotope fractionation is a serious problem in B because B has only two isotopes. Different methodologies are adopted to circumvent this drawback. The 11B/10B isotope ratio is determined with any of the three approaches during TIMS data acquisition. These approaches are(i) follow a strict protocol developed previously with certified isotopic reference material like NIST-SRM-951; (ii) use total evaporation (TE) (Foster et al., 2006); and (iii) by internal normalization (IN) based on 18O/16O ratios determined in-situ from ReO4— ions, from each filament loading, prior to mass spectrometry for boron (Aggarwal et al., 2009b). The total evaporation approach to take care of isotope fractionation in TIMS involves integration of the ion current until complete exhaustion of the sample on the filament and was proposed (Kanno, 1971) for elements with high ionization efficiencies and follow Rayleigh distillation as in the case of single-filament assembly. This total evaporation method requires less than 1 ng of boron to be loaded on the filament due to the very high sensitivity of N-TIMS of boron, and completion of the analysis within a reasonable time. This loading of about 1 ng of boron demands a strict control of boron blank during all stages of sample handling. Internal normalization is based on the invariant nature of one of the isotope amount ratios (e.g., 18O/16O) present in the sample on a given filament. The isotope fractionation factor is calculated from the 18O/16O isotope ratio by using the 187Re/185Re isotope ratio determined from ReO4— ions from the same filament. With the 18O/16O isotope ratio from the ReO4— ion, the fractionation factor is calculated for the 18O/16O ratio observed with the BO2— ion, and this factor is applied to account for isotope fractionation in the boron isotope ratio. The application of this internal normalization methodology was demonstrated on NIST-SRM-951 isotopic reference material, in sea water as well as in coral samples (Aggarwal et al., 2009b).

It has been reported that determination of d11B in forami- nifera samples with TE-NTIMS gives a bias with respect to the data obtained with MC-ICPMS. This bias is attributed to the incomplete decomposition of the organics that arise from foraminifera tests. This inference is supported by the observa- tion that the same solution during repeated analysis with TE- NTIMS over a period of a few months gives a d11B value lower by 6‰ probably due to the hydrolysis of organic matter by the acid  present  in  the  solution  (Foster,  2008).  In  the  studies performed  previously  with  N-TIMS  (H€onisch  &  Hemming, 2005; Pelejero et al., 2005; Hemming & H€onisch, 2007), each sample was analyzed with several independent filament loadings (at least three times), with strict protocol of filament heating and data acquisition, to confirm the absence of analytical artifacts such as excessive isotopic fractionation and isobaric interfer- ences on mass 42 by the organic matter. The mass spectrometric analysis runs which showed fractionation and/or isobaric interference  were  discarded,  until  three  acceptable  runs data showing no fractionation (less than 0.1‰) in 20 min of acquisition  were  obtained and  averaged. In  the  light  of these discussions, further studies are necessary to make the N-TIMS method robust and rugged to achieve precision and accuracy of better than 0.2–0.4‰, to be useful for paleo-proxy studies.

 

B.Inductively Coupled Plasma Mass Spectrometry (ICPMS)

ICPMS is a useful and quite convenient mass spectrometric method to determine the isotope ratios and concentrations of different elements in a variety of matrices. Solutions are analyzed with a pneumatic nebulizer (PN), whereas solids can directly be analyzed with laser ablation (LA). A number of commercial vendors—(e.g., Agilent [Japan], GBC Scientific [Australia], Nu Instruments [UK], Perkin Elmer [USA], Thermo Fisher [Germany]) supply a variety of ICPMS systems with different kinds of mass analyzers. These ICPMS instruments include quadrupole-based ICPMS with or without a collision or reaction cell, time-of-flight based ICPMS, high resolution double-focusing electrostatic and magnetic analyzers based ICPMS (Element 2 from Thermo and AttoM from Nu Instru- ments), and multiple collector magnetic sector based ICPMS (NuPlasma and Neptune).

Among the various types of ICPMS systems, Q-ICPMS and ToF ICPMS are employed to determine concentrations of different elements, and their isotope ratios in environmental and biological applications that do not demand high precision. These quadrupole- and ToF-based ICPMS systems are more cost- effective compared to MC-TIMS and MC-ICPMS, but provide lower precision and poor accuracy (Gregoire, 1987; Lu, 2014) in isotope ratio measurements due to Gaussian peak shapes. Therefore, these Q-ICPMS and ToF-ICPMS are not employed to determine precise and accurate isotope ratios, but are used mostly for multi-elemental analysis to determine the trace and ultra-trace concentrations of different elements in various matrices. Most of the quadrupole-based ICPMS instruments are equipped with either a dynamic reaction cell (DRC) or a collision cell to overcome the isobaric interferences from the atomic isobars as well as to eliminate polyatomic interferences (Tanner & Baranov, 1999). This removal of isobaric interference is based on the preferential chemical reaction of the analyte ion or the interfering ion with a reactive reagent gas (e.g., oxygen, ammonia, etc.), which shifts the m/z ratio and thereby chemi- cally resolves isobars. In addition, polyatomic molecular interfering ions are dissociated due to collisions with the reagent gas. Another approach is with kinetic energy discrimination with an inert gas. These systems provide an abundance sensitivity (contribution of high-abundant peak of mass M to adjacent peak at mass M 1) of 107.
A novel QQQ-ICPMS (from Agilent, 8800) with an octo- pole reaction cell is introduced recently in the market (Agilent, 2013). This triple-quad ICPMS eliminates the atomic and polyatomic isobaric interferences with the use of a collision or reaction gas in the second quadrupole, and in addition, gives a high abundance sensitivity of more than 108. This instrument needs to be evaluated for its capability, in terms of precision and accuracy, to determine boron isotope ratios.

Single-collector magnetic sector based HR-ICPMS is quite popular to analyze samples for determination of concentrations of various trace constituents, because the use of double focusing electrostatic and magnetic analyzers allows to eliminate most of the polyatomic isobaric interferences commonly encountered at m/z below 80 in Q-ICPMS. MC-ICPMS systems from Thermo as well as Nu Instruments are available at different international laboratories, and are the best to perform isotopic analysis of various elements with the highest precision (0.01% or better) and accuracies. HR-ICPMS and MC-ICPMS both have the options to use these systems at low, medium, and high mass resolutions. Experience in different international laboratories over the past decade has demonstrated that samples with a lower chemical purity, compared to that required for MC-TIMS analysis, can be analyzed conveniently with MC-ICPMS to make the latter a more popular analytical tool compared to MC- TIMS (Yang, 2009). The MC-ICPMS-based techniques are also characterized by their fast analyses that lead to high throughput, subjected to optimization of different operating parameters of ICPMS and matching the matrices of sample and standard. Boron is analyzed as Bþ ions, taking care of a tail contribution from 12Cþ, memory or carry-over effect, and control of the laboratory and procedural blank values. The standard sample bracketing (SSB) approach is popularly used to take care of mass discrimination and signal drift during data collection. Among the various types of ICPMS instruments available commercially, only the MC-ICPMS allows the determination of 11B/10B  isotopic  ratios  with  relative  precision  values  of 0.2–0.4‰ required in paleo-proxy studies and is, therefore, the most popular with bio- and geo-scientists (Rehkamper, Sch€onbachler, & Stirling, 2003). However, to achieve such high precision in the isotopic ratio data, the non-spectroscopic matrix effects, for example, the effect of Na contamination and other matrix elements present in the sample have to be checked. Because B is a light element, and there is a difference of about 10% in the atomic  masses  of the two isotopes, the  presence  of  Na (Na/B molar ratio of 20,000 and Na concentration of 6,000 ppm in solution with 150 ppb of boron) was reported to give 12% suppression in the B count rate and 8% increase in the observed 11B/10B isotopic ratio (Gregoire, 1987). Additionally, a compari- son of the matrix effects with Na, Cs, and Pb showed that the presence of heavy element causes the highest suppression effect to the intensity of boron (Gregoire, 1987). Therefore, separation and purification of boron, from bulk of matrix elements or organic impurities is one of the important pre-requisites to the determination of boron isotopic ratios with high precision and accuracy.

 

C.Mass-Bias Effect
The mass-bias effect (also known as isotope fractionation or mass discrimination) occurs in ICPMS due to space-charge effects or in the high vacuum region between sampler and skimmer cones. This effect leads to preferential extraction and transmission of the heavier isotope compared to the lighter one and, therefore, the isotope ratio data are positively biased with respect to the heavier isotope (Albarede et al., 2015). In case of boron, a mass-bias effect of 4–9% per atomic mass unit was reported with an MC-ICPMS (Thermo Axiom) system (Aggar- wal et al., 2003). However, this mass discrimination is quite stable, and can be easily corrected for with the SSB approach (Foster, 2008). Sample solutions with 20–50 ppb of boron and NIST SRM-951 boron standard of similar concentration are analyzed. A typical sequence involves the analysis of blank, standard, sample, standard, blank. This is repeated two times for every sample and the average d-11B value is calculated. It is important that the sample and the standard are matrix-matched because the presence of large amounts of other elements (e.g., Na) and the acid strength used to introduce the sample will give rise to matrix effects affecting the B isotope mass fractionation

 

D.Memory Problem
As stated previously, determination of B isotope ratios or B concentration is plagued by the carry-over effect or memory problem due to the adhering tendency of B to the instrumental components. This memory effect has been noticed by several researchers and a number of approaches have been used to minimize this effect. These approaches include a wash between analyses with ammonia solution, inject NH3 gas into the spray chamber during analysis (Al-Ammar, Gupta, & Barnes, 1999, 2000),  wash  with  NaF,  mannitol  (C6H8(OH)6),  a  wash  with
H2O2  (10%),  HF  (0.3%),  HNO3  (0.65 N),  and  finally HNO (0.05 N; Lecuyer et al., 2002). Nebulized ammonia reacts with boric acid to form ammonium borate, which is non-volatile, and is, therefore, washed out of the spray chamber without the production of Bþ ions. Detailed studies were performed on the introduction of ammonia gas into the spray chamber to optimize the NH3 flow rate (Al-Ammar, Gupta, & Barnes, 2000). It was shown that a wash time of 2 min is sufficient to get rid of the boron memory. At the same time, an enhancement in the boron signal intensity was observed, which was attributed to an increase in the thermal conductivity due to hydrogen formation from ammonia or charge exchange reaction between the positively charged nitrogen species and boron atoms (Al- Ammar, Gupta, & Barnes, 2000). Also, no analyte loss, matrix precipitation, or nebulizer blockage was observed. Most MC-ICPMS laboratories use dilute HNO3 (0.5 M) as the wash solution, for 2 min, in between the samples to minimize the memory effect in B isotope ratio measurements.
Several other approaches were tried in the past to circum- vent the ubiquitous memory problem in B concentration determinations in various matrices. These methods cannot be used in B-isotope ratio measurements with MC-ICPMS, because of the matrix effects induced by the introduction of various chemicals. A rinse solution of 0.25% (w/v) mannitol in 0.1 M NH3 was used to eliminate the boron memory effect after a 5- min wash (Sun et al., 2000) to determine B in biological samples (e.g., serum, plasma, and urine). Mannitol has been used by several researchers in view of the tendency of boron to form complexes with alcohols and polysaccharides. A rinse solution of ammonia, EDTA, surfactant Triton X100, and H2O2 was used (Wright et al., 2008) for standard sample introduction system during analysis of boron with Q-ICPMS in soil/plant samples. A mixture of 0.1 M HNO3 and 0.3M HF was used with a Teflon spray chamber (Misra et al., 2014). A demountable direct- injection high-efficiency nebulizer (d-DIHEN; Bellato, Mene- gario, & Gine, 2003) was also used to circumvent the memory effect. A comparison on the Meinhard pneumatic nebulizer with a Scott-type double-spray pass chamber and direct injection nebuliser (Smith et al., 1991) showed the advantages of DIN from the point of view of low sample consumption as well as quick wash with negligible memory. In the case of a pneumatic nebulizer, a signal of 2% of initial boron intensity, which decreased very slowly, was seen even after washing for eight minutes with a 2% HNO3 solution. With DIN, because liquid samples are transported inside a capillary by pumping at high pressure and by introducing its aerosol directly into the plasma, no spray chamber is required.

The best way to confirm the complete elimination of any memory effect is to make multiple injections of natural boron solution or NIST standard SRM-951, enriched 10B (d11B value of at least 100 or more) solution, and again natural B solution with similar concentrations of boron (Aggarwal et al., 2015, unpublished results).

In addition to extended washing with 2–3% HNO3, it was suggested that an on-peak zero blank correction (Wei et al., 2014) should be applied to account for the memory effect, particularly when analyzing samples with  widely  varying  d11B values as well as for samples with extremely small amounts (ng or less) of boron. The corrected 11B/10B isotope ratio of the sample is calculated as:

 

E.Laser Ablation ICPMS (LA-ICPMS)
Laser ablation ICPMS depends on the use of a laser to generate an aerosol of the material in an ablation cell. The generated vapors are transported with He, Ar, or Ar N2 gas into the argon plasma of ICP, where they are atomized and ionized. Different kinds of lasers have been used (Table 1),  and  involved  a  1,024 nm solid state Nd-YAG laser to start with, 532 nm (second harmonic), 266 nm (third harmonic), 213 nm (mixing of third 

TABLE 1. Different types of lasers used in LA-ICPMS for boron

 

 

 

ANGENE is pledged to providing quality specialty chemicals for use in research and development and commercial manufacturing:

CAS No. 100713-02-8

Ethanone, 1-[1-(phenylmethyl)-1H-pyrrol-2-yl]-

Catalog No.:AG0002PR MDL No.:

MF:C13H13NO MW:199.2484

CAS No. 100713-03-9

2-Phenanthridinol, 7,8,9,10-tetrahydro-

Catalog No.:AG0002PQ MDL No.:

MF:C13H13NO MW:199.2484

CAS No. 100713-31-3

Butanoic acid, 2-methyl-, 2-(4-bromophenyl)-2-oxoethyl ester

Catalog No.:AG0002PP MDL No.:

MF:C13H15BrO3 MW:299.1604

CAS No. 100713-33-5

1,3-Benzodioxole, 5-bromo-6-[[(tetrahydro-2H-pyran-2-yl)oxy]methyl]-

Catalog No.:AG0002PO MDL No.:

MF:C13H15BrO4 MW:315.1598

CAS No. 100715-61-5

1-Azabicyclo[2.2.2]oct-2-ene-3-carboxamide

Catalog No.:AG0002PN MDL No.:

MF:C8H12N2O MW:152.1937

CAS No. 10072-02-3

1,3,2-Benzodioxaphosphole, 2-ethoxy-

Catalog No.:AG0002PW MDL No.:

MF:C8H9O3P MW:184.1290

CAS No. 10072-05-6

Benzoic acid, 2-(dimethylamino)-, methyl ester

Catalog No.:AG0002PV MDL No.:MFCD00025858

MF:C10H13NO2 MW:179.2157

CAS No. 10072-09-0

3-Pyridinemethanol, 3-acetate

Catalog No.:AG0002PU MDL No.:

MF:C8H9NO2 MW:151.1626

CAS No. 10072-37-4

Benzenamine, N,N-bis(2-chloroethyl)-4-(2-phenylethenyl)-

Catalog No.:AG0002PT MDL No.:

MF:C18H19Cl2N MW:320.2562

CAS No. 10072-97-6

Pregn-4-ene-3,20-dione, 9,11-epoxy-17,21-dihydroxy-, (9β,11β)- (9CI)

Catalog No.:AG0002PS MDL No.:

MF:C21H28O5 MW:360.4440

CAS No. 100721-33-3

Acetamide, 2-chloro-N-cyclohexyl-N-phenyl-

Catalog No.:AG0002QK MDL No.:MFCD01566907

MF:C14H18ClNO MW:251.7518

CAS No. 1007215-91-9

Acetic acid, 2-[2-[2-[2-[(4-formylbenzoyl)amino]ethoxy]ethoxy]ethoxy]-

Catalog No.:AG0002Q6 MDL No.:

MF:C16H21NO7 MW:339.3404

CAS No. 1007215-94-2

3,6,9-Trioxa-12-azatridecanoic acid, 13-(4-formylphenyl)-13-oxo-, 1,1-dimethylethyl ester

Catalog No.:AG0002Q5 MDL No.:

MF:C20H29NO7 MW:395.4468

CAS No. 1007219-73-9

1H-Indazole-6-carboxylic acid, 1-methyl-, methyl ester

Catalog No.:AG0002Q4 MDL No.:MFCD11109403

MF:C10H10N2O2 MW:190.1986

CAS No. 100723-71-5

L-Proline, N-[(4-methylphenyl)sulfonyl]glycyl-

Catalog No.:AG0002QJ MDL No.:MFCD00238391

MF:C14H18N2O5S MW:326.3681

CAS No. 100723-77-1

1H-Carbazole-6-carbonitrile, 2,3,4,9-tetrahydro-

Catalog No.:AG0002QI MDL No.:MFCD12402555

MF:C13H12N2 MW:196.2478

CAS No. 1007235-33-7

1H-Indole, 5-fluoro-2-(trifluoromethyl)-

Catalog No.:AG0002Q3 MDL No.:MFCD19689276

MF:C9H5F4N MW:203.1363

CAS No. 1007235-35-9

1H-Indole, 5-chloro-2-(trifluoromethyl)-

Catalog No.:AG0002Q2 MDL No.:MFCD20227391

MF:C9H5ClF3N MW:219.5909

CAS No. 100724-01-4

2H-1,5-Benzodiazepin-2-one, 4-(2-furanyl)-1,3,4,5-tetrahydro-

Catalog No.:AG0002QH MDL No.:

MF:C13H12N2O2 MW:228.2466

CAS No. 100724-16-1

5-Pyrimidinecarboxylic acid, 4-phenyl-, ethyl ester

Catalog No.:AG0002QG MDL No.:

MF:C13H12N2O2 MW:228.2466

CAS No. 100724-38-7

Benzenamine, 4-[(2-methoxy-4-nitrophenyl)thio]-

Catalog No.:AG0002QF MDL No.:

MF:C13H12N2O3S MW:276.3110

CAS No. 100725-72-2

10H-Phenoxazine-4-carboxylic acid, methyl ester

Catalog No.:AG0002QE MDL No.:

MF:C14H11NO3 MW:241.2420

CAS No. 100726-23-6

Benzonitrile, 4-[(2-phenylhydrazinylidene)methyl]-

Catalog No.:AG0002QD MDL No.:

MF:C14H11N3 MW:221.2572

CAS No. 100727-07-9

Benzaldehyde, 4-(phenylamino)-

Catalog No.:AG0002QC MDL No.:MFCD03950803

MF:C13H11NO MW:197.2325

CAS No. 100727-30-8

1H-Isoindole-1,3(2H)-dione, 2-(2-cyclopenten-1-yl)-

Catalog No.:AG0002QB MDL No.:

MF:C13H11NO2 MW:213.2319

CAS No. 100727-33-1

4-Pyridinecarboxylic acid, 2-[(phenylmethyl)thio]-

Catalog No.:AG0002QA MDL No.:MFCD01928082

MF:C13H11NO2S MW:245.2969

CAS No. 100727-36-4

1,1'-Biphenyl, 2-(methylthio)-4'-nitro-

Catalog No.:AG0002Q9 MDL No.:MFCD21332978

MF:C13H11NO2S MW:245.2969

CAS No. 100727-49-9

2-Pyridinecarboxylic acid, 4-(phenylmethoxy)-

Catalog No.:AG0002Q8 MDL No.:MFCD11181375

MF:C13H11NO3 MW:229.2313

CAS No. 100728-48-1

Phenol, 3-methoxy-4-[2-(2-nitrophenyl)diazenyl]-

Catalog No.:AG0002Q7 MDL No.:

MF:C13H11N3O4 MW:273.2441

CAS No. 1007292-97-8

Hydrazine, [(3,5-dimethylphenyl)methyl]-

Catalog No.:AG0002Q1 MDL No.:MFCD09815888

MF:C9H14N2 MW:150.2209

CAS No. 10073-94-6

Benzoic acid, 4-(2-methyl-4-oxo-3(4H)-quinazolinyl)-, hydrazide

Catalog No.:AG0002QL MDL No.:

MF:C16H14N4O2 MW:294.3080

CAS No. 1007306-65-1

Carbamic acid, N-[[(1S,3R)-3-hydroxycyclopentyl]methyl]-, 1,1-dimethylethyl ester

Catalog No.:AG0002Q0 MDL No.:

MF:C11H21NO3 MW:215.2893

CAS No. 1007308-74-8

2,4(1H,3H)-Quinazolinedione, 7-fluoro-6-nitro-

Catalog No.:AG0002PZ MDL No.:MFCD11858258

MF:C8H4FN3O4 MW:225.1335

CAS No. 1007308-75-9

Quinazoline, 2,4-dichloro-7-fluoro-6-nitro-

Catalog No.:AG0002PY MDL No.:MFCD11858255

MF:C8H2Cl2FN3O2 MW:262.0248

CAS No. 1007311-95-6

Phosphine, dicyclohexyl[9-(3-phenylpropyl)-9H-fluoren-9-yl]-, tetrafluoroborate(1-) (1:1)

Catalog No.:AG0002PX MDL No.:

MF: MW:

CAS No. 1007311-98-9

Phosphine, (9-butyl-9H-fluoren-9-yl)dicyclohexyl-, tetrafluoroborate(1-) (1:1)

Catalog No.:AG0002QW MDL No.:

MF: MW:

CAS No. 100735-03-3

Phenothiazine, 10-[3-(dimethylamino)-2-methylpropyl]-2-nitro-, maleate (7CI)

Catalog No.:AG0002R6 MDL No.:

MF:C22H25N3O6S MW:459.5154

CAS No. 100736-83-2

Benzenaminium, N,N,N-triphenyl-, perchlorate (1:1)

Catalog No.:AG0002R5 MDL No.:

MF:C24H20ClNO4 MW:421.8729

CAS No. 1007374-49-3

Benzoic acid, 5-iodo-2-[(1-methylethyl)amino]-, methyl ester

Catalog No.:AG0002QV MDL No.:

MF:C11H14INO2 MW:319.1388

CAS No. 1007375-07-6

Benzene, 1-bromo-3-(1,1-dimethylethyl)-2-methoxy-

Catalog No.:AG0002QU MDL No.:MFCD00233138

MF:C11H15BrO MW:243.1402

CAS No. 100738-07-6

Carbamodithioic acid, decyl-, compd. with 1-decanamine (1:1) (9CI)

Catalog No.:AG0002R4 MDL No.:

MF:C21H46N2S2 MW:390.7333

CAS No. 1007386-72-2

4H-Pyrrolo[2,3-d]thiazole-5-carboxylic acid

Catalog No.:AG0002QT MDL No.:MFCD11501500

MF:C6H4N2O2S MW:168.1732

CAS No. 1007386-84-6

4H-thieno[3,2-b]pyrrole-2-carboxylic acid

Catalog No.:AG0002QS MDL No.:MFCD10657075

MF:C7H5NO2S MW:167.1851

CAS No. 1007387-40-7

3-Thiophenecarboxaldehyde, 4-[2-(4-chlorophenyl)ethyl]-

Catalog No.:AG0002QR MDL No.:

MF:C13H11ClOS MW:250.7438

CAS No. 1007387-46-3

3-Thiophenecarboxaldehyde, 4-[(4-chlorophenyl)methyl]-

Catalog No.:AG0002QQ MDL No.:

MF:C12H9ClOS MW:236.7173

CAS No. 1007387-95-2

8,10-Methano-7H-pentaleno[1,2,3-cd]pyrano[3,4-h]benzofuran-7-acetic acid, 4-(3-furanyl)tetradecahydro-α,9a,11b-trihydroxy-4a,6b,8-trimethyl-2,12-dioxo-, methyl ester, (αS,4S,4aS,6aR,6bS,7R,8R,9aS,9bS,10R,11aR,11bS)-

Catalog No.:AG0002QP MDL No.:MFCD20274890

MF: MW:

CAS No. 1007388-21-7

3-Thiophenecarboxaldehyde, 4-[2-(4-chlorophenyl)ethenyl]-

Catalog No.:AG0002QO MDL No.:

MF:C13H9ClOS MW:248.7280

CAS No. 100739-74-0

Thiourea, N-(4-methylphenyl)-N'-[[(4-methylphenyl)amino][(4-methylphenyl)imino]methyl]-

Catalog No.:AG0002R3 MDL No.:

MF:C23H24N4S MW:388.5285

CAS No. 1007390-44-4

1H-Imidazolium, 1-butyl-3-ethenyl-, salt with 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide (1:1), homopolymer

Catalog No.:AG0002QN MDL No.:MFCD18251312

MF: MW:

CAS No. 1007398-58-4

1H-Imidazolium, 1,2-dimethyl-3-octyl-, chloride (1:1)

Catalog No.:AG0002QM MDL No.:

MF:C13H27ClN2 MW:246.8199

CAS No. 10074-32-5

Stannane, diphenyldi-2-propen-1-yl-

Catalog No.:AG0002R9 MDL No.:

MF:C18H20Sn MW:355.0524

CAS No. 10074-42-7

Lithium, cyclohexyl-

Catalog No.:AG0002R8 MDL No.:

MF:C6H11Li MW:90.0925

CAS No. 10074-84-7

Disulfide, cyclohexyl methyl (8CI,9CI)

Catalog No.:AG0002R7 MDL No.:

MF:C7H14S2 MW:162.3161

CAS No. 100742-04-9

2-Pyrrolidinemethanol, 1,2-dimethyl-

Catalog No.:AG0002R2 MDL No.:

MF:C7H15NO MW:129.2001

CAS No. 100742-32-3

2H-1-Benzopyran-2-one, 7-methoxy-3-(3-methyl-2-buten-1-yl)-

Catalog No.:AG0002R1 MDL No.:

MF:C15H16O3 MW:244.2857

CAS No. 100742-56-1

2(3H)-Benzoxazolone, 3-acetyl-6-(4-chlorobenzoyl)-

Catalog No.:AG0002R0 MDL No.:

MF:C16H10ClNO4 MW:315.7079

CAS No. 100743-00-8

1H-Pyrazolo[3,4-b]quinoline, 4-chloro-3-methyl-

Catalog No.:AG0002QZ MDL No.:

MF:C11H8ClN3 MW:217.6543

CAS No. 100743-01-9

1H-Pyrazolo[3,4-b]quinoline, 3-methyl-4-phenoxy-

Catalog No.:AG0002QY MDL No.:

MF:C17H13N3O MW:275.3046

CAS No. 100743-02-0

1H-Pyrazolo[3,4-b]quinoline, 4-(4-methoxyphenoxy)-3-methyl-

Catalog No.:AG0002QX MDL No.:

MF:C18H15N3O2 MW:305.3306

CAS No. 100743-68-8

Propanoic acid, 2-(1-ethoxyethoxy)-, potassium salt (1:1)

Catalog No.:AG0002RZ MDL No.:

MF:C7H13KO4 MW:200.2740

CAS No. 100743-74-6

1-Imidazolidinecarboxylic acid, 2-oxo-, 4-nitrophenyl ester

Catalog No.:AG0002RY MDL No.:

MF:C10H9N3O5 MW:251.1956

CAS No. 100743-90-6

Benzoic acid, 4-(acetyloxy)-, 4-(methoxycarbonyl)phenyl ester

Catalog No.:AG0002RX MDL No.:

MF:C17H14O6 MW:314.2895

CAS No. 1007455-21-1

Benzoic acid, 2-bromo-4-fluoro-5-methoxy-

Catalog No.:AG0002RM MDL No.:MFCD13193242

MF:C8H6BrFO3 MW:249.0338

CAS No. 1007455-22-2

Benzoic acid, 2-bromo-4-fluoro-5-methoxy-, methyl ester

Catalog No.:AG0002RL MDL No.:MFCD20482372

MF:C9H8BrFO3 MW:263.0604

CAS No. 1007455-25-5

1H-Isoindol-1-one, 5-fluoro-2,3-dihydro-6-hydroxy-

Catalog No.:AG0002RK MDL No.:

MF:C8H6FNO2 MW:167.1371

CAS No. 1007455-28-8

Benzoic acid, 6-bromo-2-fluoro-3-methoxy-, methyl ester

Catalog No.:AG0002RJ MDL No.:MFCD20482377

MF:C9H8BrFO3 MW:263.0604

CAS No. 1007455-29-9

Benzoic acid, 6-cyano-2-fluoro-3-methoxy-, methyl ester

Catalog No.:AG0002RI MDL No.:

MF:C10H8FNO3 MW:209.1738

CAS No. 1007455-31-3

1H-Isoindol-1-one, 7-fluoro-2,3-dihydro-6-Methoxy-

Catalog No.:AG0002RH MDL No.:

MF:C9H8FNO2 MW:181.1637

CAS No. 1007462-48-7

1H-Pyrazole-4-ethanol, 1,3,5-trimethyl-

Catalog No.:AG0002RF MDL No.:MFCD08060042

MF:C8H14N2O MW:154.2096

CAS No. 100747-20-4

Glycine, N-(3-hydroxypropyl)-

Catalog No.:AG0002RW MDL No.:

MF:C5H11NO3 MW:133.1457

CAS No. 100747-44-2

Propanedioic acid, 2-(2,3-butadien-1-yl)-, 1,3-dimethyl ester

Catalog No.:AG0002RV MDL No.:

MF:C9H12O4 MW:184.1892

CAS No. 100747-46-4

4,5-Hexadienoic acid, 2-(phenylsulfonyl)-, methyl ester

Catalog No.:AG0002RU MDL No.:

MF:C13H14O4S MW:266.3129

CAS No. 100747-62-4

6H-[1]Benzopyrano[4,3-b]quinolin-6-one, 10-methyl-

Catalog No.:AG0002RT MDL No.:

MF:C17H11NO2 MW:261.2747

CAS No. 100747-79-3

Benzenamine, N-(2-methyl-1-cyclohexen-1-yl)-N-2-propen-1-yl-

Catalog No.:AG0002RS MDL No.:

MF:C16H21N MW:227.3446

CAS No. 100747-80-6

Benzenamine, N-1-cyclohexen-1-yl-N-2-propen-1-yl-

Catalog No.:AG0002RR MDL No.:

MF:C15H19N MW:213.3181

CAS No. 100747-87-3

1,3,4-Thiadiazole-3(2H)-carboxaldehyde, 5-methyl-2-thioxo-

Catalog No.:AG0002RQ MDL No.:

MF:C4H4N2OS2 MW:160.2174

CAS No. 1007476-82-5

Butanoic-3,3-d2 acid, 2-oxo-, sodium salt (1:1)

Catalog No.:AG0002RE MDL No.:

MF: MW:

CAS No. 1007476-86-9

2-NP-AHD-13C3

Catalog No.:AG0002RD MDL No.:

MF:C10H8N4O4 MW:251.1729

CAS No. 1007478-57-0

INDEX NAME NOT YET ASSIGNED

Catalog No.:AG0002RC MDL No.:

MF:C10H5D4N3O4 MW:239.2208

CAS No. 100748-03-6

3-Pyridinemethanamine, N-(3,4-dihydro-2,2,5,8-tetramethyl-2H-1-benzopyran-6-yl)-

Catalog No.:AG0002RP MDL No.:

MF:C19H24N2O MW:296.4067

CAS No. 100748-65-0

2(1H)-Quinolinone, 7-bromo-4-hydroxy-

Catalog No.:AG0002RO MDL No.:

MF:C9H6BrNO2 MW:240.0534

CAS No. 100748-67-2

2(1H)-Quinolinone, 4-hydroxy-7-nitro-

Catalog No.:AG0002RN MDL No.:

MF:C9H6N2O4 MW:206.1549

CAS No. 1007488-78-9

1H-Pyrazole-1-propanamine, N-methyl-

Catalog No.:AG0002RB MDL No.:MFCD08701102

MF:C7H13N3 MW:139.1982

CAS No. 100749-12-0

3-Cyclobutene-1,2-dione, 3,4-bis(cyclohexylamino)-

Catalog No.:AG0002S3 MDL No.:MFCD00179349

MF:C16H24N2O2 MW:276.3740

CAS No. 100749-27-7

1,5-Pentanedione, 2-(methylsulfinyl)-1,5-diphenyl-

Catalog No.:AG0002S2 MDL No.:

MF:C18H18O3S MW:314.3987

CAS No. 100749-28-8

1,5-Pentanedione, 5-(4-chlorophenyl)-2-(methylsulfinyl)-1-phenyl-

Catalog No.:AG0002S1 MDL No.:

MF:C18H17ClO3S MW:348.8438

CAS No. 100749-49-3

Acetamide, N-phenyl-2,2-bis(phenylsulfinyl)-

Catalog No.:AG0002S0 MDL No.:

MF:C20H17NO3S2 MW:383.4839

CAS No. 10075-05-5

3-Penten-2-one, 5,5,5-trifluoro-4-methyl-

Catalog No.:AG0002SO MDL No.:MFCD23382133

MF:C6H7F3O MW:152.1144

CAS No. 10075-06-6

2-Butenoic acid, 4,4,4-trifluoro-3-phenyl-, ethyl ester

Catalog No.:AG0002SN MDL No.:

MF:C12H11F3O2 MW:244.2097

CAS No. 10075-09-9

10-Octadecenoic acid, 9-hydroxy-, methyl ester, (10E)-

Catalog No.:AG0002SM MDL No.:

MF:C19H36O3 MW:312.4873

CAS No. 10075-11-3

10,12-Octadecadienoic acid, 9-hydroxy-, (9R,10E,12Z)-

Catalog No.:AG0002SL MDL No.:MFCD00084832

MF:C18H32O3 MW:296.4449

CAS No. 10075-13-5

Phosphonic acid, (2-chloro-1,1,3,3-tetrafluoroallyl)-, dimethyl ester (8CI)

Catalog No.:AG0002SK MDL No.:

MF:C5H6ClF4O3P MW:256.5197

CAS No. 10075-38-4

2-Butene, 1,3-dichloro-, (2Z)-

Catalog No.:AG0002SJ MDL No.:

MF:C4H6Cl2 MW:124.9964

CAS No. 10075-48-6

1H-Indole, 5-bromo-3-methyl-

Catalog No.:AG0002SI MDL No.:MFCD04038746

MF:C9H8BrN MW:210.0705

CAS No. 10075-49-7

1H-Indole, 5-bromo-1,3-dimethyl-

Catalog No.:AG0002SH MDL No.:MFCD21988755

MF:C10H10BrN MW:224.0971

CAS No. 10075-50-0

1H-Indole, 5-bromo-

Catalog No.:AG0002SG MDL No.:MFCD00005670

MF:C8H6BrN MW:196.0439

CAS No. 10075-52-2

1H-Indole, 5-bromo-1-methyl-

Catalog No.:AG0002SF MDL No.:MFCD00159857

MF:C9H8BrN MW:210.0705

CAS No. 10075-61-3

Naphthalene, 1,3-dimethoxy-

Catalog No.:AG0002SE MDL No.:MFCD00980804

MF:C12H12O2 MW:188.2225

CAS No. 10075-62-4

Naphthalene, 1,4-dimethoxy-

Catalog No.:AG0002SD MDL No.:MFCD00052378

MF:C12H12O2 MW:188.2225

CAS No. 10075-63-5

Naphthalene, 1,5-dimethoxy-

Catalog No.:AG0002SC MDL No.:MFCD00086779

MF:C12H12O2 MW:188.2225

CAS No. 10075-66-8

1,8-Dimethoxynaphthalene

Catalog No.:AG0002SB MDL No.:

MF:C12H12O2 MW:188.2225

CAS No. 10075-68-0

Naphthalene, 1,4,5,8-tetramethoxy-

Catalog No.:AG0002SA MDL No.:

MF:C14H16O4 MW:248.2744

CAS No. 10075-69-1

1,5-Naphthalenediamine, N1,N1,N5,N5-tetramethyl-

Catalog No.:AG0002S9 MDL No.:

MF:C14H18N2 MW:214.3061

CAS No. 10075-72-6

Naphthalene, 1-(methylthio)-

Catalog No.:AG0002S8 MDL No.:

MF:C11H10S MW:174.2621

CAS No. 10075-77-1

Naphthalene, 2,6-bis(methylthio)-

Catalog No.:AG0002S7 MDL No.:MFCD06656543

MF:C12H12S2 MW:220.3537

CAS No. 10075-78-2

Naphthalene, 2,7-bis(methylthio)-

Catalog No.:AG0002S6 MDL No.:MFCD06656542

MF:C12H12S2 MW:220.3537

CAS No. 10075-85-1

Anthracene, 9,10-bis(2-phenylethynyl)-

Catalog No.:AG0002S5 MDL No.:MFCD00012050

MF:C30H18 MW:378.4639

CAS No. 10075-93-1

1,6-Pyrenediamine, N1,N1,N6,N6-tetramethyl-

Catalog No.:AG0002S4 MDL No.:

MF:C20H20N2 MW:288.3862

CAS No. 100750-05-8

L-Phenylalanine-α,β-t2, N-[(9H-fluoren-9-ylmethoxy)carbonyl]- (9CI)

Catalog No.:AG0002TC MDL No.:MFCD00112977

MF:C24H21NO4 MW:387.4278

CAS No. 100750-39-8

Ethanone, 1-[4-(acetyloxy)-2-phenyl-1H-pyrrol-1-yl]-

Catalog No.:AG0002TB MDL No.:

MF:C14H13NO3 MW:243.2579

CAS No. 100750-40-1

1H-Pyrrol-3-ol, 5-phenyl-

Catalog No.:AG0002TA MDL No.:

MF:C10H9NO MW:159.1846

CAS No. 1007501-25-8

1H-Pyrazole-4-methanamine, N,α,1,3,5-pentamethyl-

Catalog No.:AG0002T0 MDL No.:MFCD08060064

MF:C9H17N3 MW:167.2514

CAS No. 1007503-15-2

1H-Pyrazole-3-carboxylic acid, 1-ethyl-, ethyl ester

Catalog No.:AG0002SZ MDL No.:MFCD08700856

MF:C8H12N2O2 MW:168.1931

CAS No. 1007504-11-1

1H-Pyrazole-4-methanol, α,1,3,5-tetramethyl-

Catalog No.:AG0002SY MDL No.:MFCD08700900

MF:C8H14N2O MW:154.2096

CAS No. 100751-62-0

Naphthalene, 2-bromo-6-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-

Catalog No.:AG0002T9 MDL No.:

MF:C17H23BrOSi MW:351.3534

CAS No. 100751-63-1

2-Naphthalenemethanol, 6-bromo-

Catalog No.:AG0002T8 MDL No.:MFCD09842470

MF:C11H9BrO MW:237.0926

CAS No. 100751-65-3

Naphthalene, 2-bromo-6-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-

Catalog No.:AG0002T7 MDL No.:MFCD11044858

MF:C16H21BrOSi MW:337.3268

CAS No. 1007516-30-4

1H-Pyrazole-4-propanol, 1-ethyl-

Catalog No.:AG0002SX MDL No.:MFCD08059737

MF:C8H14N2O MW:154.2096

CAS No. 1007517-63-6

1H-Pyrazole-1-propanol, γ-methyl-

Catalog No.:AG0002SW MDL No.:MFCD08701090

MF:C7H12N2O MW:140.1830

CAS No. 1007517-75-0

1H-Pyrazole-1-propanol, β-methyl-

Catalog No.:AG0002SV MDL No.:MFCD08059960

MF:C7H12N2O MW:140.1830

CAS No. 1007517-99-8

1H-Pyrazole-1-propanamine, N,3,5-trimethyl-

Catalog No.:AG0002SU MDL No.:MFCD08687688

MF:C9H17N3 MW:167.2514

CAS No. 1007518-49-1

1-Propanone, 1-(1-methyl-1H-pyrazol-4-yl)-

Catalog No.:AG0002ST MDL No.:MFCD08060047

MF:C7H10N2O MW:138.1671

CAS No. 100752-53-2

Propanal, 3-(2-naphthalenylthio)-

Catalog No.:AG0002T6 MDL No.:

MF:C13H12OS MW:216.2988

CAS No. 100752-58-7

Benzonitrile, 4-(1-oxo-3-phenyl-2-propyn-1-yl)-

Catalog No.:AG0002T5 MDL No.:

MF:C16H9NO MW:231.2488

CAS No. 100752-60-1

1-Penten-4-yn-3-one, 1-phenyl-5-(trimethylsilyl)-

Catalog No.:AG0002T4 MDL No.:

MF:C14H16OSi MW:228.3617

CAS No. 100752-97-4

9H-Thioxanthen-9-one, diethyl-

Catalog No.:AG0002T3 MDL No.:

MF:C17H16OS MW:268.3733

CAS No. 1007520-12-8

1H-Pyrazole-4-methanamine, N,3,5-trimethyl-1-(1-methylethyl)-

Catalog No.:AG0002SS MDL No.:MFCD08691487

MF:C10H19N3 MW:181.2780

CAS No. 1007520-65-1

1H-Pyrazole-4-methanamine, N-ethyl-1-(1-methylethyl)-

Catalog No.:AG0002SR MDL No.:MFCD08700733

MF:C9H17N3 MW:167.2514

CAS No. 100753-38-6

Carbamic acid, cyano-, methyl ester, dimer (9CI)

Catalog No.:AG0002T2 MDL No.:

MF:C3H4N2O2 MW:100.0761

CAS No. 1007536-67-5

Urea, N'-(3,4-dichlorophenyl)-N,N-di(methyl-d3)-

Catalog No.:AG0002SQ MDL No.:

MF:C9H4Cl2D6N2O MW:239.1315

CAS No. 1007538-66-0

1H-Pyrazole-4-methanamine, 3-methyl-

Catalog No.:AG0002SP MDL No.:MFCD05664573

MF:C5H9N3 MW:111.1451

CAS No. 100754-69-6

2-Propen-1-one, 2-(4-morpholinylmethyl)-1-(2,3,4-trimethoxyphenyl)-

Catalog No.:AG0002T1 MDL No.:

MF:C17H23NO5 MW:321.3682

CAS No. 100754-93-6

Benzeneacetic acid, 2-[(2-chloro-6-fluorophenyl)amino]-

Catalog No.:AG0002U1 MDL No.:

MF:C14H11ClFNO2 MW:279.6940

CAS No. 1007541-19-6

1H-Pyrazol-4-amine, 1,3-diethyl-

Catalog No.:AG0002TN MDL No.:

MF:C7H13N3 MW:139.1982

CAS No. 1007541-72-1

1H-Pyrazole-4-carboxylic acid, 3-ethyl-

Catalog No.:AG0002TM MDL No.:MFCD07367322

MF:C6H8N2O2 MW:140.1399

CAS No. 1007541-75-4

1H-Pyrazole-4-carboxylic acid, 3-propyl-

Catalog No.:AG0002TL MDL No.:MFCD08144099

MF:C7H10N2O2 MW:154.1665

CAS No. 1007541-87-8

1H-Pyrazole-4-carboxylic acid, 3-(2-methylphenyl)-

Catalog No.:AG0002TK MDL No.:

MF:C11H10N2O2 MW:202.2093

CAS No. 1007542-01-9

1H-Pyrazole-4-carboxylic acid, 3,5-dimethyl-1-(1-methylethyl)-

Catalog No.:AG0002TJ MDL No.:MFCD06260701

MF:C9H14N2O2 MW:182.2197

CAS No. 1007542-22-4

1H-Pyrazole-4-methanol, 1-(1-methylethyl)-

Catalog No.:AG0002TI MDL No.:MFCD08059963

MF:C7H12N2O MW:140.1830

CAS No. 100756-23-8

Phosphonic acid, monoethyl ester, mixt. with 2,4,5,6-tetrachloro-1,3-benzenedicarbonitrile (9CI)

Catalog No.:AG0002U0 MDL No.:

MF:C10H6Cl4N2O3P+ MW:374.9520

CAS No. 100756-77-2

1,2-Benzenedicarbonitrile, 3,6-dihydroxy-4-methyl-

Catalog No.:AG0002TZ MDL No.:

MF:C9H6N2O2 MW:174.1561

CAS No. 100757-06-0

Benzoic acid, 3,5-dinitro-, 2-[1-[(diethylamino)methyl]-1,2-dihydro-2-oxo-3H-indol-3-ylidene]hydrazide

Catalog No.:AG0002TY MDL No.:

MF:C20H20N6O6 MW:440.4094

CAS No. 100757-08-2

Benzoic acid, 3,5-dinitro-, 2-[5-chloro-1,2-dihydro-1-(4-morpholinylmethyl)-2-oxo-3H-indol-3-ylidene]hydrazide

Catalog No.:AG0002TX MDL No.:

MF:C20H17ClN6O7 MW:488.8380

CAS No. 100757-15-1

Benzoic acid, 3,5-dinitro-, 2-[5-chloro-1-[(diethylamino)methyl]-1,2-dihydro-2-oxo-3H-indol-3-ylidene]hydrazide

Catalog No.:AG0002TW MDL No.:

MF:C20H19ClN6O6 MW:474.8545

CAS No. 100757-52-6

Hydrazinecarboximidamide, 2,2'-(1-propyl-1,2-ethanediylidene)bis- (9CI)

Catalog No.:AG0002TV MDL No.:

MF:C7H16N8 MW:212.2555

CAS No. 100757-73-1

Borinic acid, B-butyl-B-phenyl-

Catalog No.:AG0002TU MDL No.:

MF:C10H15BO MW:162.0365

CAS No. 1007573-18-3

[1,1'-Biphenyl]-4-methanamine, N-(2,3-dihydro-1H-inden-2-yl)-3,5-difluoro-3'-(1H-1,2,4-triazol-5-yl)-

Catalog No.:AG0002TH MDL No.:

MF:C24H20F2N4 MW:402.4392

CAS No. 1007578-82-6

Benzamide, 3-bromo-5-methyl-

Catalog No.:AG0002TG MDL No.:MFCD18204794

MF:C8H8BrNO MW:214.0592

CAS No. 1007578-86-0

BENZAMIDE, 3-CHLORO-4-HYDROXY-

Catalog No.:AG0002TF MDL No.:MFCD11130855

MF:C7H6ClNO2 MW:171.5810

CAS No. 1007579-67-0

Benzaldehyde, 4-iodo-2-(trifluoromethyl)-

Catalog No.:AG0002TE MDL No.:

MF:C8H4F3IO MW:300.0164

CAS No. 100758-02-9

Methanone, 1,4-phenylenebis[(2-methylphenyl)- (9CI)

Catalog No.:AG0002TT MDL No.:

MF:C22H18O2 MW:314.3771

CAS No. 100758-03-0

Methanone, 1,4-phenylenebis[(2-methoxyphenyl)- (9CI)

Catalog No.:AG0002TS MDL No.:

MF:C22H18O4 MW:346.3759

CAS No. 100758-27-8

4-Octene-1,7-diyne, (4Z)-

Catalog No.:AG0002TR MDL No.:

MF:C8H8 MW:104.1491

CAS No. 100758-62-1

4,7-Methanoisobenzofuran-1-ol, octahydro-

Catalog No.:AG0002TQ MDL No.:

MF:C9H14O2 MW:154.2063

CAS No. 100759-12-4

2-Oxiranecarboxaldehyde, 3-methyl-3-(4,8,12-trimethyltridecyl)-

Catalog No.:AG0002TP MDL No.:

MF:C20H38O2 MW:310.5145

CAS No. 100759-95-3

β-D-Glucopyranose, 2-deoxy-2-[(3-hydroxy-1-oxotetradecyl)amino]-, 1,3,4-triacetate 6-(dihydrogen phosphate)

Catalog No.:AG0002TO MDL No.:

MF: MW:

CAS No. 1007596-63-5

1-Piperidinecarboxylic acid, 4-amino-3-hydroxy-, phenylmethyl ester, (3S,4S)-

Catalog No.:AG0002TD MDL No.:MFCD22518380

MF:C13H18N2O3 MW:250.2936

CAS No. 1007596-95-3

1-Piperidinecarboxylic acid, 4-amino-3-hydroxy-, 1,1-dimethylethyl ester, (3R,4R)-

Catalog No.:AG0002U5 MDL No.:MFCD18072074

MF:C10H20N2O3 MW:216.2774

CAS No. 10076-00-3

2,6,8,10-Dodecatetraenamide, N-(2-methylpropyl)-, (2E,6E,8E,10E)-

Catalog No.:AG0002UQ MDL No.:

MF:C16H25NO MW:247.3758

CAS No. 10076-31-0

1-Propanamine, N,N,2,2-tetramethyl-

Catalog No.:AG0002UP MDL No.:

MF:C7H17N MW:115.2166

CAS No. 10076-35-4

Benzoic acid, 4-[[5-amino-4-[2-(aminocarbonyl)hydrazinylidene]pentyl][(4-methylphenyl)sulfonyl]amino]-, ethyl ester

Catalog No.:AG0002UO MDL No.:

MF:C22H29N5O5S MW:475.5612

CAS No. 10076-48-9

Propanoic acid, 2,2-dimethoxy-, methyl ester

Catalog No.:AG0002UN MDL No.:MFCD00048066

MF:C6H12O4 MW:148.1571

CAS No. 10076-57-0

Pentane, 1,1'-[(1-methylethylidene)bis(oxy)]bis-

Catalog No.:AG0002UM MDL No.:

MF:C13H28O2 MW:216.3602

CAS No. 100760-04-1

Benzenemethanol, 4-bromo-α-methyl-, (αS)-

Catalog No.:AG0002UJ MDL No.:MFCD06201860

MF:C8H9BrO MW:201.0605

CAS No. 100760-33-6

1,3-Dithiole, 4-phenyl-2-(4-phenyl-1,3-dithiol-2-ylidene)-, (2Z)-

Catalog No.:AG0002UI MDL No.:

MF:C18H12S4 MW:356.5479

CAS No. 1007605-44-8

Benzonitrile, 2,5-difluoro-4-methoxy-

Catalog No.:AG0002U4 MDL No.:MFCD06246886

MF:C8H5F2NO MW:169.1282

CAS No. 100764-16-7

2-Propenal, 3-cyclohexyl-2-methyl-, (2E)-

Catalog No.:AG0002UH MDL No.:

MF:C10H16O MW:152.2334

CAS No. 100764-57-6

2-Butenal, 2-methyl-4-phenyl-, (2Z)-

Catalog No.:AG0002UG MDL No.:

MF:C11H12O MW:160.2124

CAS No. 1007649-71-9

Acetamide, N-[3,4-dihydro-3-oxo-4-(2-propen-1-yl)-2H-1,4-benzoxazin-6-yl]-

Catalog No.:AG0002U3 MDL No.:

MF:C13H14N2O3 MW:246.2619

CAS No. 100765-42-2

3-Pentanone, 1-(4-chlorophenyl)-4-methyl-

Catalog No.:AG0002UF MDL No.:MFCD11655320

MF:C12H15ClO MW:210.6999

CAS No. 100765-45-5

3-Pentanone, 1-(4-methoxyphenyl)-4-methyl-

Catalog No.:AG0002UE MDL No.:

MF:C13H18O2 MW:206.2808

CAS No. 100766-33-4

Naphthalene, dihexyl- (6CI,7CI,9CI)

Catalog No.:AG0002UD MDL No.:

MF:C22H32 MW:296.4895

CAS No. 100766-35-6

Octadecanoic acid, hexabromo-

Catalog No.:AG0002UC MDL No.:

MF:C18H30Br6O2 MW:757.8536

CAS No. 100766-72-1

Naphthalene, undecyl- (9CI)

Catalog No.:AG0002UB MDL No.:

MF:C21H30 MW:282.4629

CAS No. 100768-45-4

Pyrido[3,2-d]pyrimidine, 2,4-dibenzamido-6-methyl- (7CI)

Catalog No.:AG0002UA MDL No.:

MF:C22H17N5O2 MW:383.4027

CAS No. 10077-96-0

Carbamic acid, (2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-, methyl ester (9CI)

Catalog No.:AG0002UL MDL No.:

MF:C13H15N3O3 MW:261.2765

CAS No. 100770-17-0

Phenothiazine, 10-[N-[2-(dimethylamino)ethyl]glycyl]-, maleate (1:1) (7CI)

Catalog No.:AG0002U9 MDL No.:

MF:C22H25N3O5S MW:443.5160

CAS No. 100773-13-5

Octagermane

Catalog No.:AG0002U8 MDL No.:

MF:Ge8H18 MW:599.2629

CAS No. 100777-46-6

Benzene, 1-chloro-5-methoxy-2-methyl-4-nitro-

Catalog No.:AG0002U7 MDL No.:MFCD13191701

MF:C8H8ClNO3 MW:201.6070

CAS No. 100779-91-7

1H-Pyrrole, 1-(3-bromopropyl)-

Catalog No.:AG0002U6 MDL No.:MFCD00191324

MF:C7H10BrN MW:188.0650

CAS No. 1007798-23-3

2-Pyridinamine, 5-chloro-N-[(4-chlorophenyl)methyl]-

Catalog No.:AG0002U2 MDL No.:

MF:C12H10Cl2N2 MW:253.1272

CAS No. 10078-27-0

10H-Phenothiazine, 2-chloro-10-[3-(4-methyl-1-piperazinyl)propyl]-, 5-oxide

Catalog No.:AG0002UK MDL No.:

MF:C20H24ClN3OS MW:389.9421

CAS No. 10078-54-3

2-Propen-1-one, 3-(dimethylamino)-1-(3,4,5-trimethoxyphenyl)-

Catalog No.:AG0002VF MDL No.:

MF:C14H19NO4 MW:265.3050

CAS No. 10078-93-0

Boranediamine, 1-chloro-N,N,N'-tris(trimethylsilyl)- (9CI)

Catalog No.:AG0002VE MDL No.:

MF:C9H28BClN2Si3 MW:294.8525

CAS No. 100780-04-9

[4,4'-Biphenanthrene]-3,3'-diol

Catalog No.:AG0002VD MDL No.:

MF:C28H18O2 MW:386.4413

CAS No. 100780-08-3

Benzenepropanoic acid, β-phenyl-, 4-methyl-2-thioxo-3(2H)-thiazolyl ester

Catalog No.:AG0002VC MDL No.:

MF:C19H17NO2S2 MW:355.4738

CAS No. 100780-09-4

Benzeneacetic acid, α-phenyl-, 4-methyl-2-thioxo-3(2H)-thiazolyl ester

Catalog No.:AG0002VB MDL No.:

MF:C18H15NO2S2 MW:341.4472

CAS No. 100780-24-3

Benzene, 1,1'-[3-butenylidenebis(sulfonyl)]bis- (9CI)

Catalog No.:AG0002VA MDL No.:

MF:C16H16O4S2 MW:336.4258

CAS No. 100780-27-6

Benzene, 1,1'-[[1-(2-propyn-1-yl)-3-buten-1-ylidene]bis(sulfonyl)]bis-

Catalog No.:AG0002V9 MDL No.:

MF:C19H18O4S2 MW:374.4738

CAS No. 100780-36-7

Benzene, 1-[(1E)-2-nitro-1-propen-1-yl]-4-(phenylmethoxy)-

Catalog No.:AG0002V8 MDL No.:

MF:C16H15NO3 MW:269.2952

CAS No. 1007802-68-7

Benzamide, N-(4-cyanophenyl)-3,4-difluoro-

Catalog No.:AG0002UW MDL No.:MFCD09951416

MF:C14H8F2N2O MW:258.2229

CAS No. 100781-49-5

3H-1,2,4-Triazole-3-thione, 1,2-dihydro-1,5-bis(4-methoxyphenyl)-

Catalog No.:AG0002V7 MDL No.:

MF:C16H15N3O2S MW:313.3742

CAS No. 100781-89-3

Phosphorous acid, bis([1,1'-biphenyl]-2-yl) octadecyl ester (9CI)

Catalog No.:AG0002V6 MDL No.:

MF:C42H55O3P MW:638.8581

CAS No. 100781-90-6

Phosphorous acid, octadecyl diphenyl ester

Catalog No.:AG0002V5 MDL No.:

MF:C30H47O3P MW:486.6661

CAS No. 100781-94-0

2-Propenethioamide, 2-cyano-3-(phenylamino)-

Catalog No.:AG0002V4 MDL No.:

MF:C10H9N3S MW:203.2636

CAS No. 100781-95-1

2-Propenethioamide, 2-cyano-3-[(4-methylphenyl)amino]-

Catalog No.:AG0002V3 MDL No.:

MF:C11H11N3S MW:217.2901

CAS No. 100783-71-9

Benzenemethanaminium, N,N,N-tripropyl-

Catalog No.:AG0002V2 MDL No.:

MF:C16H28N+ MW:234.4002

CAS No. 100784-26-7

1H-Pyrazole-4-carboxylic acid, 5-(aminosulfonyl)-3-chloro-1-methyl-, ethyl ester

Catalog No.:AG0002V0 MDL No.:

MF:C7H10ClN3O4S MW:267.6900

CAS No. 100784-27-8

1H-Pyrazole-4-carboxylic acid, 5-(aminosulfonyl)-3-chloro-1-methyl-, methyl ester

Catalog No.:AG0002UZ MDL No.:MFCD13152198

MF:C6H8ClN3O4S MW:253.6634

CAS No. 100784-53-0

3-Pyridinecarbonitrile, 1,6-dihydro-6-oxo-2,4-diphenyl-

Catalog No.:AG0002UY MDL No.:

MF:C18H12N2O MW:272.3007

CAS No. 100784-63-2

Germane, trimethyl[4-(trifluoromethyl)phenyl]-

Catalog No.:AG0002UX MDL No.:

MF:C10H13F3Ge MW:262.8454

CAS No. 1007840-14-3

Benzeneacetic acid, 5-hydroxy-2-(phenylmethoxy)-

Catalog No.:AG0002UV MDL No.:

MF:C15H14O4 MW:258.2693

CAS No. 1007840-62-1

D-Homocysteine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-S-(triphenylmethyl)-

Catalog No.:AG0002UU MDL No.:MFCD05663440

MF:C38H33NO4S MW:599.7379

CAS No. 1007847-70-2

Pyridine, 2-[(tetrahydro-2H-pyran-4-yl)oxy]-6-(tributylstannyl)-

Catalog No.:AG0002UT MDL No.:MFCD12198113

MF:C22H39NO2Sn MW:468.2516

CAS No. 1007847-72-4

Benzaldehyde, 4-(2-thienylmethyl)-

Catalog No.:AG0002US MDL No.:

MF:C12H10OS MW:202.2722

CAS No. 1007847-74-6

Thiophene, 2-[[4-(bromomethyl)phenyl]methyl]-

Catalog No.:AG0002UR MDL No.:MFCD13151981

MF:C12H11BrS MW:267.1847

CAS No. 1007847-76-8

1,3,2-Dioxaborolane, 4,4,5,5-tetramethyl-2-[4-(2-thienylmethyl)phenyl]-

Catalog No.:AG0002W1 MDL No.:MFCD11841077

MF:C17H21BO2S MW:300.2234

CAS No. 1007847-80-4

2-Pyrrolidinecarboxamide, 1-(2-furanylmethyl)-

Catalog No.:AG0002W0 MDL No.:MFCD11055269

MF:C10H14N2O2 MW:194.2304

CAS No. 100785-98-6

2H-1-Benzopyran-2-one, 7-[[(1R,4aS,6R,8aS)-decahydro-6-hydroxy-5,5,8a-trimethyl-2-methylene-1-naphthalenyl]methyl]-

Catalog No.:AG0002W2 MDL No.:

MF:C24H30O3 MW:366.4932

CAS No. 1007869-57-9

4-Piperidinamine, 1-[4-(aminomethyl)phenyl]-N,N-dimethyl-

Catalog No.:AG0002VZ MDL No.:MFCD12439390

MF:C14H23N3 MW:233.3525

CAS No. 1007869-61-5

3-Piperidinamine, 1-(4-aminophenyl)-N,N-dimethyl-

Catalog No.:AG0002VY MDL No.:

MF:C13H21N3 MW:219.3259

CAS No. 1007870-02-1

3-Pyrrolidinecarboxamide, N-methyl-

Catalog No.:AG0002VX MDL No.:MFCD12198083

MF:C6H12N2O MW:128.1723

CAS No. 1007871-85-3

1,3-Dioxane-4-acetic acid, 6-[(1E)-2-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]ethenyl]-2,2-dimethyl-, 1,1-dimethylethyl ester

Catalog No.:AG0002VW MDL No.:MFCD18083696

MF:C29H40FN3O6S MW:577.7078

CAS No. 1007873-66-6

4-Oxazolecarboxylic acid, 2-methyl-5-(3-methylphenyl)-

Catalog No.:AG0002VV MDL No.:

MF:C12H11NO3 MW:217.2206

CAS No. 1007873-90-6

1-Azetidinecarboxylic acid, 2-(aminomethyl)-, 1,1-dimethylethyl ester, (2S)-

Catalog No.:AG0002VU MDL No.:MFCD17215571

MF:C9H18N2O2 MW:186.2514

CAS No. 1007874-03-4

Benzenepropanoic acid, β-chloro-3-fluoro-α-oxo-, methyl ester

Catalog No.:AG0002VT MDL No.:

MF:C10H8ClFO3 MW:230.6201

CAS No. 1007874-87-4

Imidazo[2,1-b]thiazole-5-carboxylic acid, 6-(trifluoromethyl)-

Catalog No.:AG0002VS MDL No.:MFCD11889976

MF:C7H3F3N2O2S MW:236.1711

CAS No. 1007875-06-0

Benzenepropanoic acid, β-chloro-2-fluoro-α-oxo-, methyl ester

Catalog No.:AG0002VR MDL No.:

MF:C10H8ClFO3 MW:230.6201

CAS No. 1007877-68-0

1H-Indole-7-methanamine, α-methyl-

Catalog No.:AG0002VQ MDL No.:

MF:C10H12N2 MW:160.2157

CAS No. 1007881-21-1

L-Threonine, N-(methoxycarbonyl)-O-methyl-

Catalog No.:AG0002VP MDL No.:

MF:C7H13NO5 MW:191.1818

CAS No. 1007881-27-7

L-Valine, N-5-pyrimidinyl-

Catalog No.:AG0002VO MDL No.:MFCD13193566

MF:C9H13N3O2 MW:195.2184

CAS No. 1007881-98-2

1-Pyrrolidinecarboxylic acid, 2-[[[2-(4-bromophenyl)-2-oxoethyl]amino]carbonyl]-, 1,1-dimethylethyl ester, (2S)-

Catalog No.:AG0002VN MDL No.:MFCD21496634

MF:C18H23BrN2O4 MW:411.2902

CAS No. 1007882-04-3

1-Pyrrolidinecarboxylic acid, 2-[5-(4-bromophenyl)-1H-imidazol-2-yl]-, 1,1-dimethylethyl ester, (2S)-

Catalog No.:AG0002VM MDL No.:MFCD19982645

MF:C18H22BrN3O2 MW:392.2902

CAS No. 1007882-12-3

1-Pyrrolidinecarboxylic acid, 2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-yl]-, 1,1-dimethylethyl ester, (2S)-

Catalog No.:AG0002VL MDL No.:MFCD20527700

MF:C24H34BN3O4 MW:439.3555

CAS No. 1007882-23-6

1-Pyrrolidinecarboxylic acid, 2,2'-([1,1'-biphenyl]-4,4'-diyldi-1H-iMidazole-5,2-diyl)bis-, 1,1'-bis(1,1-diMethylethyl) ester, (2S,2'S)-

Catalog No.:AG0002VK MDL No.:MFCD28404669

MF:C36H44N6O4 MW:624.7724

CAS No. 1007882-27-0

1H-Imidazole, 5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-

Catalog No.:AG0002VJ MDL No.:

MF:C26H28N6 MW:424.5407

CAS No. 1007882-58-7

1-Pyrrolidinecarboxylic acid, 2-(1H-imidazol-2-yl)-, 1,1-dimethylethyl ester, (2S)-

Catalog No.:AG0002VI MDL No.:MFCD16660093

MF:C12H19N3O2 MW:237.2982

CAS No. 1007882-59-8

1-Pyrrolidinecarboxylic acid, 2-(5-bromo-1H-imidazol-2-yl)-, 1,1-dimethylethyl ester, (2S)-

Catalog No.:AG0002VH MDL No.:MFCD16620748

MF:C12H18BrN3O2 MW:316.1942

CAS No. 1007883-29-5

Ethanone, 2-bromo-1-(2-chloro-5-pyrimidinyl)-

Catalog No.:AG0002VG MDL No.:MFCD15526622

MF:C6H4BrClN2O MW:235.4658

CAS No. 10079-78-4

Benzenesulfonamide, 4-(3-aminopropyl)-

Catalog No.:AG0002W3 MDL No.:

MF:C9H14N2O2S MW:214.2847

CAS No. 10079-93-3

Benzenesulfonamide, 4-[2-[[(phenylamino)thioxomethyl]amino]ethyl]-

Catalog No.:AG0002WI MDL No.:

MF:C15H17N3O2S2 MW:335.4444

CAS No. 100791-00-2

3-Pyridinecarbonyl chloride, 4-chloro-

Catalog No.:AG0002WH MDL No.:MFCD09864939

MF:C6H3Cl2NO MW:176.0001

CAS No. 100791-01-3

2H-Imidazol-2-one, 1,3-dihydro-4-propyl-

Catalog No.:AG0002WG MDL No.:MFCD19217440

MF:C6H10N2O MW:126.1564

CAS No. 100791-94-4

3-Pentenamide

Catalog No.:AG0002WF MDL No.:

MF:C5H9NO MW:99.1311

CAS No. 100792-01-6

2H-1,3-Oxazin-2-one, tetrahydro-5-methyl-

Catalog No.:AG0002WE MDL No.:

MF:C5H9NO2 MW:115.1305

CAS No. 100794-10-3

Glycine, L-histidyl-L-histidyl-

Catalog No.:AG0002WD MDL No.:

MF:C14H19N7O4 MW:349.3452

CAS No. 100794-17-0

Benzene, (4,4-dimethylcyclohexyl)-

Catalog No.:AG0002WC MDL No.:

MF:C14H20 MW:188.3086

CAS No. 100794-31-8

1-Piperidineethanol, α-[(2-bromophenoxy)methyl]-

Catalog No.:AG0002WB MDL No.:MFCD03670777

MF:C14H20BrNO2 MW:314.2181

CAS No. 100794-93-2

Butanamide, N-(2,4-dichlorophenyl)-3-(diethylamino)-

Catalog No.:AG0002WA MDL No.:

MF:C14H20Cl2N2O MW:303.2274

CAS No. 100795-23-1

Acetamide, N-(4-methoxy-2-methyl-6-quinolinyl)-

Catalog No.:AG0002W9 MDL No.:MFCD06681161

MF:C13H14N2O2 MW:230.2625

CAS No. 100795-25-3

6-Quinolinecarboxylic acid, 4-amino-2-methyl-, ethyl ester

Catalog No.:AG0002W8 MDL No.:

MF:C13H14N2O2 MW:230.2625

CAS No. 100795-92-4

2,4-Thiazolidinedione, 3-(2-aminoethyl)-5-[(4-methoxyphenyl)methylene]-

Catalog No.:AG0002W7 MDL No.:MFCD01830171

MF:C13H14N2O3S MW:278.3269

CAS No. 100796-79-0

Propanedioic acid, 2-(1H-benzotriazol-1-ylimino)-, 1,3-diethyl ester

Catalog No.:AG0002W6 MDL No.:

MF:C13H14N4O4 MW:290.2747

CAS No. 100799-15-3

Heptane, 1-(2-butoxyethoxy)-

Catalog No.:AG0002W5 MDL No.:

MF:C13H28O2 MW:216.3602

CAS No. 100799-16-4

Heptane, 1-[2-(2-methylpropoxy)ethoxy]-

Catalog No.:AG0002W4 MDL No.:

MF:C13H28O2 MW:216.3602

CAS No. 1008-01-1

7H-Purine, 7-methyl-6-(methylthio)-

Catalog No.:AG0002WS MDL No.:

MF:C7H8N4S MW:180.2302

CAS No. 1008-07-7

1H-Indole-3-carboxaldehyde, 7-chloro-

Catalog No.:AG0002WR MDL No.:MFCD06657153

MF:C9H6ClNO MW:179.6030

CAS No. 1008-08-8

3H-Purine, 3-methyl-6-(methylthio)-

Catalog No.:AG0002WQ MDL No.:

MF:C7H8N4S MW:180.2302

CAS No. 1008-13-5

1H-Inden-1-one, 5-chloro-2,3-dihydro-4-methyl-

Catalog No.:AG0002WP MDL No.:

MF:C10H9ClO MW:180.6309

CAS No. 1008-15-7

Benzonitrile, 2-(2-chloroacetyl)-

Catalog No.:AG0002WO MDL No.:

MF:C9H6ClNO MW:179.6030

CAS No. 1008-19-1

Naphthalene, 1,2,3,4-tetrahydro-5-methoxy-

Catalog No.:AG0002WN MDL No.:MFCD22536129

MF:C11H14O MW:162.2283

CAS No. 1008-27-1

Benzo[b]thiophene, 3,5,7-trimethyl-

Catalog No.:AG0002WM MDL No.:

MF:C11H12S MW:176.2780

CAS No. 1008-30-6

3H-1,2,4-Triazol-3-one, 2,4-dihydro-4-phenyl-

Catalog No.:AG0002WL MDL No.:MFCD00266689

MF:C8H7N3O MW:161.1607

CAS No. 1008-46-4

3H-Pyrrolizin-3-one, 1-(dimethylamino)-

Catalog No.:AG0002WK MDL No.:

MF:C9H10N2O MW:162.1885

CAS No. 1008-50-0

1,2-Benzisoxazole-3-carboxamide, 4,5,6,7-tetrahydro-

Catalog No.:AG0002WJ MDL No.:MFCD16885703

MF:C8H10N2O2 MW:166.1772

CAS No. 1008-57-7

Benzo[b]thiophene, 3,4,7-trimethyl-

Catalog No.:AG0002XG MDL No.:

MF:C11H12S MW:176.2780

CAS No. 1008-63-5

Benzeneacetic acid, α-(aminomethyl)-, (αR)-

Catalog No.:AG0002XF MDL No.:MFCD10698585

MF:C9H11NO2 MW:165.1891

CAS No. 1008-65-7

Phenol, 2-(1,3,4-oxadiazol-2-yl)-

Catalog No.:AG0002XE MDL No.:MFCD00020713

MF:C8H6N2O2 MW:162.1454

CAS No. 1008-72-6

Benzenesulfonic acid, 2-formyl-, sodium salt (1:1)

Catalog No.:AG0002XD MDL No.:MFCD00007478

MF:C7H5NaO4S MW:208.1670

CAS No. 1008-75-9

Isoxazole, 3-methyl-5-phenyl-

Catalog No.:AG0002XC MDL No.:MFCD00020810

MF:C10H9NO MW:159.1846

CAS No. 1008-79-3

3H-Pyrazol-3-one, 1,2-dihydro-1-phenyl-

Catalog No.:AG0002XB MDL No.:MFCD00129721

MF:C9H8N2O MW:160.1726

CAS No. 1008-88-4

Pyridine, 3-phenyl-

Catalog No.:AG0002XA MDL No.:MFCD00006380

MF:C11H9N MW:155.1959

CAS No. 1008-89-5

Pyridine, 2-phenyl-

Catalog No.:AG0002X9 MDL No.:MFCD00006280

MF:C11H9N MW:155.1959

CAS No. 1008-91-9

Piperazine, 1-(4-pyridinyl)-

Catalog No.:AG0002X8 MDL No.:MFCD00040745

MF:C9H13N3 MW:163.2196

CAS No. 1008-92-0

1,4-Benzodioxin-2-carbonitrile, 2,3-dihydro-

Catalog No.:AG0002X7 MDL No.:MFCD00068066

MF:C9H7NO2 MW:161.1574

CAS No. 1008-94-2

Oxazole, 5-(4-chlorophenyl)-

Catalog No.:AG0002X6 MDL No.:MFCD09258870

MF:C9H6ClNO MW:179.6030

CAS No. 1008-95-3

Benzenamine, 4-(5-oxazolyl)-

Catalog No.:AG0002X5 MDL No.:MFCD00052192

MF:C9H8N2O MW:160.1726

CAS No. 10080-04-3

Benzenesulfonamide, 4-[2-[[(phenylamino)carbonyl]amino]ethyl]-

Catalog No.:AG0002X4 MDL No.:

MF:C15H17N3O3S MW:319.3788

CAS No. 10080-39-4

Mercury, chloro-1-cyclohexen-1-yl- (7CI,8CI,9CI)

Catalog No.:AG0002X3 MDL No.:

MF:C6H9ClHg MW:317.1787

CAS No. 10080-41-8

Cyclopentanone, hydrazone

Catalog No.:AG0002X2 MDL No.:

MF:C5H10N2 MW:98.1463

CAS No. 10080-44-1

1-Propanone, 1-(2-hydroxy-5-methylphenyl)-, oxime

Catalog No.:AG0002X1 MDL No.:

MF:C10H13NO2 MW:179.2157

CAS No. 10080-68-9

2-Butenoic acid, 4-hydroxy-, ethyl ester, (2E)-

Catalog No.:AG0002X0 MDL No.:

MF:C6H10O3 MW:130.1418

CAS No. 10080-92-9

3-Pyrrolidinecarboxylic acid, 1-methyl-5-oxo-, ethyl ester

Catalog No.:AG0002WZ MDL No.:

MF:C8H13NO3 MW:171.1937

CAS No. 100800-07-5

4-Morpholineethanamine, α-methyl-β-phenyl-

Catalog No.:AG0002WY MDL No.:MFCD06654908

MF:C13H20N2O MW:220.3107

CAS No. 100800-40-6

Benzenamine, 4-[3-(4-morpholinyl)propoxy]-

Catalog No.:AG0002WX MDL No.:MFCD11593604

MF:C13H20N2O2 MW:236.3101

CAS No. 100800-85-9

Hexanamide, 6-[[(4-methylphenyl)sulfonyl]amino]-

Catalog No.:AG0002WW MDL No.:

MF:C13H20N2O3S MW:284.3745

CAS No. 100803-30-3

Benzenemethanamine, N,N-bis[4-(2,2-diphenylethenyl)phenyl]-

Catalog No.:AG0002WV MDL No.:

MF:C47H37N MW:615.8034

CAS No. 100803-82-5

L-Phenylalanine, N-benzoyl-2,3-didehydrovalyl- (9CI)

Catalog No.:AG0002WU MDL No.:

MF:C21H22N2O4 MW:366.4104

CAS No. 100806-77-7

Benzenemethanol, 4-(4,6-dimethyl-2-pyrimidinyl)-

Catalog No.:AG0002WT MDL No.:

MF:C13H14N2O MW:214.2631

CAS No. 1008121-01-4

Benzamide, 5-chloro-N-(2-chloro-6-nitrophenyl)-2-hydroxy-

Catalog No.:AG0002XN MDL No.:MFCD23703038

MF:C13H8Cl2N2O4 MW:327.1196

CAS No. 1008130-15-1

1H-Imidazole-2-carboxylic acid, 1-amino-, ethyl ester

Catalog No.:AG0002XM MDL No.:

MF:C6H9N3O2 MW:155.1546

CAS No. 1008130-51-5

2,3,5-FURANTRICARBOXALDEHYDE

Catalog No.:AG0002XL MDL No.:

MF:C7H4O4 MW:152.1043

CAS No. 1008138-66-6

Pyridine, 2-methyl-5-nitro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-

Catalog No.:AG0002XK MDL No.:MFCD13195046

MF:C12H17BN2O4 MW:264.0854

CAS No. 1008138-73-5

3-Pyridinecarboxylic acid, 5-amino-6-methyl-, ethyl ester

Catalog No.:AG0002XJ MDL No.:MFCD18256589

MF:C9H12N2O2 MW:180.2038

CAS No. 1008139-18-1

Carbamic acid, N-(2-methyl-5-nitro-3-pyridinyl)-, 1,1-dimethylethyl ester

Catalog No.:AG0002XI MDL No.:

MF:C11H15N3O4 MW:253.2545

CAS No. 1008139-25-0

Boronic acid, B-4-isoxazolyl-

Catalog No.:AG0002XH MDL No.:MFCD06657892

MF:C3H4BNO3 MW:112.8798

© 2019 Angene International Limited. All rights Reserved.